<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.pharmaceutical-business-review.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5b4a2memory_pharmaceuticals_achieves_enrollment_goal_for_schizophrenia_/</loc>
		<lastmod>2018-07-04T15:30:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/594b3pharmoss_phase_iia_osteoarthritic_pain_trial_fails_end/</loc>
		<lastmod>2018-07-04T15:30:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fd496teva_wins_fda_approval_for_generic_asthma/</loc>
		<lastmod>2018-07-04T15:30:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/194b3lumen_wins_fda_clearance_for_fibernet_embolic_protection_s/</loc>
		<lastmod>2018-07-04T15:30:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4a4b1genvec_reports_topline_interim_results_from_phase_iii_pancreatic_cancer_/</loc>
		<lastmod>2018-07-04T15:30:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/04487pharmathene_signs_commercialization_agreement_with_medison_p/</loc>
		<lastmod>2018-07-04T15:30:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7c485knopp_neurosciences_completes_series_b2_fina/</loc>
		<lastmod>2018-07-04T15:30:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a2480chelsea_completes_enrollment_for_phase_ii_hypotension_/</loc>
		<lastmod>2018-07-04T15:30:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1d4b1encorium_signs_new_business_contracts_worth_65_mi/</loc>
		<lastmod>2018-07-04T15:30:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc48esalix_granted_new_us_patent_for_rifa/</loc>
		<lastmod>2018-07-04T15:30:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d149ducb_reports_positive_results_from_two_phase_iii_arthritis_t/</loc>
		<lastmod>2018-07-04T15:30:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6b4aacytogenix_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:30:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a9485metabolex_reports_positive_results_from_phase_ii_dyslipidemia_/</loc>
		<lastmod>2018-07-04T15:30:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8f4b1icon_and_lilly_sign_agreement_to_manage_clinical_data_management_bus/</loc>
		<lastmod>2018-07-04T15:30:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9f4bawellesse_launches_liquid_vitam/</loc>
		<lastmod>2018-07-04T15:30:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/784a6torreypines_licenses_posiphen_bisnorcymcerine_and_phenserine_to_qr_p/</loc>
		<lastmod>2018-07-04T15:30:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f6481mylan_wins_fda_approval_for_fluoxetine_cap/</loc>
		<lastmod>2018-07-04T15:30:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/be4baallion_healthcare_and_under_one_roof_form_partne/</loc>
		<lastmod>2018-07-04T15:30:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6a4aeaccera_to_launch_axona_in_us_for_alzheimers_di/</loc>
		<lastmod>2018-07-04T15:30:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6b489bioreliance_signs_manufacturing_agreement_with_provecs_me/</loc>
		<lastmod>2018-07-04T15:30:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5e49eastrazeneca_appoints_new_president_of_us_bus/</loc>
		<lastmod>2018-07-04T15:30:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f5499pharming_signs_licensing_agreement_with_aslan_/</loc>
		<lastmod>2018-07-04T15:30:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ee48dthallion_initiates_enrollment_for_phase_ii_melanoma_/</loc>
		<lastmod>2018-07-04T15:30:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5e48dsalient_surgical_names_new_vice_president_of_human_reso/</loc>
		<lastmod>2018-07-04T15:30:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cd4a8supergen_names_new_chief_scientific_of/</loc>
		<lastmod>2018-07-04T15:30:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1d4a1genzyme_and_icgeb_form_collabor/</loc>
		<lastmod>2018-07-04T15:30:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7b4a9teva_and_active_biotech_complete_enrollment_for_phase_iii_ms_/</loc>
		<lastmod>2018-07-04T15:30:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/66484patheon_relaunches_alliance_with_de/</loc>
		<lastmod>2018-07-04T15:30:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e54adcelator_initiates_enrollment_for_phase_ii_leukemia_/</loc>
		<lastmod>2018-07-04T15:30:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f149earagon_surgical_wins_fda_clearance_for_intelliseal/</loc>
		<lastmod>2018-07-04T15:30:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/844bdgalapagos_and_merck_serono_sign_new_collaboration_agree/</loc>
		<lastmod>2018-07-04T15:30:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a6490novabay_initiates_enrollment_for_phase_ii_uti_/</loc>
		<lastmod>2018-07-04T15:30:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1f486numerate_raises_4_million_in_series_a_fina/</loc>
		<lastmod>2018-07-04T15:30:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e84a4xtls_phase_iib_pain_trial_fails_end/</loc>
		<lastmod>2018-07-04T15:30:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cd481sol_gel_technologies_raises_9_million_in_fina/</loc>
		<lastmod>2018-07-04T15:30:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aa4b5cardiac_dimensions_names_new_vice_president_o/</loc>
		<lastmod>2018-07-04T15:30:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5a4b4proteo_initiates_patient_recruitment_for_phase_ii_carcinoma_/</loc>
		<lastmod>2018-07-04T15:30:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ironwoods-duzallo-gets-fda-approval-for-gout-associated-hyperuricemia-220817-5906167/</loc>
		<lastmod>2018-07-04T15:30:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ligand-to-be-paid-by-wuxi-for-licensing-clinical-stage-anti-pd-1-antibody-210817-5905036/</loc>
		<lastmod>2018-07-04T15:30:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/samsung-bioepis-takeda-to-co-develop-multiple-novel-biologic-therapies-210817-5904988/</loc>
		<lastmod>2018-07-04T15:30:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7e4afsequenom_acquires_clinical_diagnostics_labor/</loc>
		<lastmod>2018-07-04T15:30:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d6481innocoll_wins_fda_fast_track_designation_for_gentamicin_surgical_im/</loc>
		<lastmod>2018-07-04T15:30:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/96491ascent_therapeutics_names_new_ceo_and_head_of_discovery_res/</loc>
		<lastmod>2018-07-04T15:30:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0d4a3interna_technologies_and_cenix_bioscience_sign_research_agre/</loc>
		<lastmod>2018-07-04T15:30:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0a48est_jude_medical_wins_japanese_approval_for_victory_pacem/</loc>
		<lastmod>2018-07-04T15:30:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-merck-get-fda-approval-for-expanded-use-of-ovarian-cancer-drug-210817-5904965/</loc>
		<lastmod>2018-07-04T15:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-mmv-begin-patient-trial-of-antimalarial-compound-in-africa-210817-5904548/</loc>
		<lastmod>2018-07-04T15:31:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/us-department-of-defense-to-launch-study-on-pluristems-plx-r18-cell-therapy-5903797/</loc>
		<lastmod>2018-07-04T15:31:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ef4a3global_med_technologies_names_ne/</loc>
		<lastmod>2018-07-04T15:31:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d44afprovectus_adds_sixth_center_to_phase_ii_melanoma_/</loc>
		<lastmod>2018-07-04T15:31:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e14a7zygem_and_vwr_international_sign_distribution_agre/</loc>
		<lastmod>2018-07-04T15:31:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/atreca-raises-35m-to-advance-novel-cancer-immunotherapies-1808117-5903780/</loc>
		<lastmod>2018-07-04T15:31:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-gets-fda-nod-for-blood-cancer-treatment-besponsa-180817-5903340/</loc>
		<lastmod>2018-07-04T15:31:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d049dlife_science_pharmaceuticals_signs_licensing_agreement_with_a/</loc>
		<lastmod>2018-07-04T15:31:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5c4bcmylans_anda_wins_fda_approval_for_depression/</loc>
		<lastmod>2018-07-04T15:31:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-to-deploy-insilicos-ai-technology-for-drug-discovery-170817-5902278/</loc>
		<lastmod>2018-07-04T15:31:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec-acquires-aptuit-for-300m-170817-5902429/</loc>
		<lastmod>2018-07-04T15:31:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b84b9medx_signs_manufacturing_and_distribution_agreement_with_naimcoric/</loc>
		<lastmod>2018-07-04T15:31:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/15498patheon_and_senopsys_form_all/</loc>
		<lastmod>2018-07-04T15:31:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2f49dsorin_group_and_sphere_medical_sign_development_agre/</loc>
		<lastmod>2018-07-04T15:31:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seattle-genetics-gets-fda-priority-review-for-adcetris-in-cutaneous-t-cell-lymphoma-170817-5902412/</loc>
		<lastmod>2018-07-04T15:31:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mateons-ovarian-cancer-treatment-ca4p-shows-favorable-results-in-focus-study-170817-5902112/</loc>
		<lastmod>2018-07-04T15:31:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2a493abingdon_life_sciences_extends_alliance_with_stason_pharmaceut/</loc>
		<lastmod>2018-07-04T15:31:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8549eunited_therapeuticss_oral_pah_trial_fails_primary_end/</loc>
		<lastmod>2018-07-04T15:31:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alvogen-to-acquire-russia-based-omega-bittner-160817-5901353/</loc>
		<lastmod>2018-07-04T15:31:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aradigm-gets-nih-grant-for-linhaliq-in-pulmonary-non-tuberculous-mycobacteria-treatment-160817-5901340/</loc>
		<lastmod>2018-07-04T15:31:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-lifts-hold-on-multikines-phase-3-head-and-neck-cancer-trial-160817-5901262/</loc>
		<lastmod>2018-07-04T15:31:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/07499lilly_and_united_therapeutics_sign_license_and_supply_agre/</loc>
		<lastmod>2018-07-04T15:31:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/47497neuronexus_and_philips_sign_research_agre/</loc>
		<lastmod>2018-07-04T15:31:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9c4bchydromer_signs_sales_representation_agreement_with_hng_me/</loc>
		<lastmod>2018-07-04T15:31:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f4496plethora_reports_encouraging_results_from_erectile_dysfunction_/</loc>
		<lastmod>2018-07-04T15:31:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8c49dbiopath_signs_drug_manufacturing_agreement_with_althea_technol/</loc>
		<lastmod>2018-07-04T15:31:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bms-kidney-cancer-drug-met-co-primary-endpoint-in-checkmate-trial-160817-5901008/</loc>
		<lastmod>2018-07-04T15:31:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/h3-biomedicine-gets-fdaorphan-drug-status-for-acute-myelogenous-leukemia-treatment-150817-5900325/</loc>
		<lastmod>2018-07-04T15:31:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/vicarius-pharma-secures-218m-financing-150817-5900324/</loc>
		<lastmod>2018-07-04T15:31:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/014a5intellidot_signs_agreement_with_iatric_sy/</loc>
		<lastmod>2018-07-04T15:31:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7c48bprotokinetix_signs_collaborative_research_agre/</loc>
		<lastmod>2018-07-04T15:31:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/624aeziopharm_reports_positive_results_from_phase_i_sarcoma_/</loc>
		<lastmod>2018-07-04T15:31:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/744afcodexis_and_dyadic_sign_licensing_agre/</loc>
		<lastmod>2018-07-04T15:31:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/124a4medtronic_wins_ce_mark_for_mrconditional_pacemaker_s/</loc>
		<lastmod>2018-07-04T15:31:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ophthotechs-wet-amd-drug-fovista-fails-in-phase-3-amd-trial-140817-5900086/</loc>
		<lastmod>2018-07-04T15:31:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oxford-biomedica-announces-collaboration-for-gene-and-cell-therapy-manufacturing-140817-5899749/</loc>
		<lastmod>2018-07-04T15:31:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pharmatech-liquid-drugs-recalled-in-us-over-bacterial-contamination-140817-5899728/</loc>
		<lastmod>2018-07-04T15:31:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/peregrine-pharmaceuticals-cuts-20-of-workforce-to-reduce-costs-and-achieve-profitability-140817-5899492/</loc>
		<lastmod>2018-07-04T15:31:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/apellis-raises-60m-in-new-funding-round-110817-5898557/</loc>
		<lastmod>2018-07-04T15:31:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gilead-gets-fda-priority-review-for-bictegravir-regimen-for-hiv-treatment-110817-5898547/</loc>
		<lastmod>2018-07-04T15:31:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sk-capital-to-acquire-perrigos-israeli-api-business-110817-5898467/</loc>
		<lastmod>2018-07-04T15:31:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celgene-sutro-revise-2014-immuno-oncology-collaboration-110817-5898164/</loc>
		<lastmod>2018-07-04T15:31:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/index-secures-fda-orphan-drug-designation-for-cobitolimod-100817-5897347/</loc>
		<lastmod>2018-07-04T15:31:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/heron-initiates-phase-3-trial-for-htx-011-in-postoperative-pain-100817-5897303/</loc>
		<lastmod>2018-07-04T15:31:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/allegros-luminate-succeeds-in-phase-2-diabetic-macular-edema-trial-100817-5897139/</loc>
		<lastmod>2018-07-04T15:31:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cancer-research-uk-biotecnol-to-begin-trials-of-novel-immuno-oncology-treatment-100817-5896889/</loc>
		<lastmod>2018-07-04T15:31:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/mylan-launches-generic-antiretroviral-medicine-efavirenz-emtricitabine-tenofovir-disoproxil-fumarate-in-canada_104642-5898974/</loc>
		<lastmod>2018-07-04T15:31:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clinigen-gets-ec-nod-for-updates-to-cardioxane-product-information-090817-5895815/</loc>
		<lastmod>2018-07-04T15:31:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roche-dermira-partner-to-develop-dermatitis-drug-lebrikizumab-090817-5895702/</loc>
		<lastmod>2018-07-04T15:31:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tissue-regenix-acquires-cellright-technologies-090817-5895833/</loc>
		<lastmod>2018-07-04T15:31:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amylyx-pharmaceuticals-doses-first-patient-in-phase-ii-clinical-trial-of-amx0035-090817-5895970/</loc>
		<lastmod>2018-07-04T15:31:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech-gets-fda-priority-review-for-zelboraf-in-erdheim-chester-disease-080817-5894500/</loc>
		<lastmod>2018-07-04T15:31:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oxford-biomedica-secures-mhra-licence-for-commercial-supply-in-uk-080817-5894480/</loc>
		<lastmod>2018-07-04T15:31:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zynerbas-cannabis-based-epilepsy-gel-fails-in-phase-2-trial-080817-5894304/</loc>
		<lastmod>2018-07-04T15:31:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbvies-mavyret-secures-fda-approval-for-chronic-hepatitis-c-treatment-070817-5893163/</loc>
		<lastmod>2018-07-04T15:31:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hitgen-leo-pharma-to-collaborate-on-small-molecule-discovery-070817-5893150/</loc>
		<lastmod>2018-07-04T15:31:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lillys-migraine-drug-lasmiditan-succeeds-in-second-phase-3-trial-070817-5892850/</loc>
		<lastmod>2018-07-04T15:31:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-and-cardurion-pharmaceuticals-launch-cardiovascular-development-partnership-5890583/</loc>
		<lastmod>2018-07-04T15:31:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/janssens-ra-drug-sirukumab-fails-to-get-fda-advisory-committee-nod-040817-5891952/</loc>
		<lastmod>2018-07-04T15:31:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/scientists-develop-new-drug-that-could-treat-and-limit-parkinsons-disease-040817-5891974/</loc>
		<lastmod>2018-07-04T15:31:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-to-acquire-ifm-therapeutics-to-expand-cancer-pipeline-040817-5891576/</loc>
		<lastmod>2018-07-04T15:31:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/orbsen-gets-european-approval-to-conduct-diabetic-kidney-disease-trial-for-obrcel-m-030817-5890565/</loc>
		<lastmod>2018-07-04T15:31:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-for-astrazenecas-acalabrutinib-030817-5890501/</loc>
		<lastmod>2018-07-04T15:31:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uks-nice-turns-down-roches-bladder-cancer-drug-on-cost-and-clinical-evidence-030817-5890213/</loc>
		<lastmod>2018-07-04T15:31:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/amgen-allergan-submit-biologics-license-application-for-abp-980-010817-5889194/</loc>
		<lastmod>2018-07-04T15:31:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/flex-pharma-launches-als-phase-2-study-with-flx-787-in-us-5889068/</loc>
		<lastmod>2018-07-04T15:31:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-generex-to-evaluate-keytruda-ae37-combination-for-triple-negative-breast-cancer-020817-5889049/</loc>
		<lastmod>2018-07-04T15:31:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristol-myers-squibbs-opdivo-gets-fda-nod-for-colorectal-cancer-subtype-020817-5888691/</loc>
		<lastmod>2018-07-04T15:31:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kite-seeks-european-approval-for-axicabtagene-ciloleucel-010817-5887517/</loc>
		<lastmod>2018-07-04T15:31:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/galera-gets-promising-innovative-medicines-designation-for-gc4419-in-uk-010817-5887537/</loc>
		<lastmod>2018-07-04T15:31:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/labcorp-to-acquire-clinical-trials-firm-chiltern-for-12bn-010817-5887170/</loc>
		<lastmod>2018-07-04T15:31:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-launches-generic-epiduo-in-us-310717-5886083/</loc>
		<lastmod>2018-07-04T15:31:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbvies-maviret-approved-in-europe-for-chronic-hepatitis-c-310717-5885695/</loc>
		<lastmod>2018-07-04T15:31:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/evotec-to-acquire-aptuit-310717-5889178/</loc>
		<lastmod>2018-07-04T15:32:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-imfinzi-tremelimumab-fails-to-improve-pfs-in-phase-3-lung-cancer-trial-270717-5884555/</loc>
		<lastmod>2018-07-04T15:32:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/evotec-storm-expand-collaboration-on-rna-epigenetic-platform-270717-5883889/</loc>
		<lastmod>2018-07-04T15:32:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eagle-gets-complete-response-letter-from-fda-on-stroke-drug-ryanodex-270717-5883907/</loc>
		<lastmod>2018-07-04T15:32:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-to-stop-30-drug-developments-to-focus-on-core-therapies-270717-5883443/</loc>
		<lastmod>2018-07-04T15:32:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/venatorx-pharmaceuticals-receives-94-million-award-from-carb-x-to-develop-a-new-class-of-antibiotic-to-combat-multi-drug-resistant-bacteria-5885521/</loc>
		<lastmod>2018-07-04T15:32:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/venatorx-raises-42m-in-new-funding-round-260717-5882342/</loc>
		<lastmod>2018-07-04T15:32:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celgene-to-pay-280m-to-settle-false-claims-act-litigation-in-us-260717-5882322/</loc>
		<lastmod>2018-07-04T15:32:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mercks-keytruda-fails-to-improve-survival-in-phase-3-head-and-neck-cancer-trial-260717-5881910/</loc>
		<lastmod>2018-07-04T15:32:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chicago-jury-orders-abbvie-to-pay-150m-in-punitive-damages-to-injured-man-250717-5880879/</loc>
		<lastmod>2018-07-04T15:32:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lilly-and-nektar-to-jointly-develop-and-commercialize-autoimmune-therapy-250717-5880852/</loc>
		<lastmod>2018-07-04T15:32:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mitsubishi-tanabe-to-acquire-neuroderm-for-11bn-250717-5880385/</loc>
		<lastmod>2018-07-04T15:32:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/bayers-phase-2-clinical-trial-of-monotherapy-for-second-line-mesothelioma-fails-250717-5882635/</loc>
		<lastmod>2018-07-04T15:32:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d9485inovio_reports_positive_interim_results_from_phase_iii_hepatitis_/</loc>
		<lastmod>2018-07-04T15:32:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4d49ddebiopharm_and_pharmaleads_sign_licensing_agre/</loc>
		<lastmod>2018-07-04T15:32:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b14bbgilead_receives_notification_of_anda_filing_for_tr/</loc>
		<lastmod>2018-07-04T15:32:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/brainstorm-secures-16m-grant-for-nurown-trial-in-als-240717-5879393/</loc>
		<lastmod>2018-07-04T15:32:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alzheimers-drug-reduces-25-of-inflammation-related-to-metabolic-syndrome-240717-5879347/</loc>
		<lastmod>2018-07-04T15:32:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/17483viacor_initiates_treatment_in_heart_failure_/</loc>
		<lastmod>2018-07-04T15:32:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f64a2stem_cell_sciences_announces_validation_of_european_ires_technology_p/</loc>
		<lastmod>2018-07-04T15:32:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ibm-canadian-university-research-shows-machine-learning-algorithms-can-predict-schizophrenia-240717-5879297/</loc>
		<lastmod>2018-07-04T15:32:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-receives-fda-approval-for-self-injectable-benlysta-formulation-240717-5881007/</loc>
		<lastmod>2018-07-04T15:32:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/incyte-launches-phase-3-trial-of-itacitinib-for-acute-graft-versus-host-disease-210717-5877734/</loc>
		<lastmod>2018-07-04T15:32:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e1489boehringer_ingelheim_advances_cancer_drug_to_phase_iii_st/</loc>
		<lastmod>2018-07-04T15:32:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ff49cmidatech_establishes_new_drug_development_subsidiary_in_switze/</loc>
		<lastmod>2018-07-04T15:32:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/534b4nanosonics_appoints_european_distributors_for_infection_control_pr/</loc>
		<lastmod>2018-07-04T15:32:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c948agenaeras_q3_net_loss_na/</loc>
		<lastmod>2018-07-04T15:32:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6e4b1neurogen_divests_noncore_a/</loc>
		<lastmod>2018-07-04T15:32:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-grants-tentative-approval-for-mercks-insulin-glargine-injection-210717-5877719/</loc>
		<lastmod>2018-07-04T15:32:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/leo-pharma-gets-ec-nod-for-psoriasis-treatment-kyntheum-210717-5877371/</loc>
		<lastmod>2018-07-04T15:32:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tiziana-launches-phase-iia-hepatocellular-carcinoma-trial-of-milciclib-200717-5876618/</loc>
		<lastmod>2018-07-04T15:32:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ab499generex_and_shreya_life_introduce_oral_insulin_in_/</loc>
		<lastmod>2018-07-04T15:32:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2e4a1daiichi_sankyo_initiates_clinical_studies_of_antiinfluenza/</loc>
		<lastmod>2018-07-04T15:32:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/80493vernalis_appoints_new_ceo_an/</loc>
		<lastmod>2018-07-04T15:32:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8049ebioanalytical_systems_names_new_coo_of_scientific_ser/</loc>
		<lastmod>2018-07-04T15:32:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4a4a1pfizer_launches_new_stem_cell_research/</loc>
		<lastmod>2018-07-04T15:32:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vertex-reports-positive-data-from-cystic-fibrosis-trials-200717-5876644/</loc>
		<lastmod>2018-07-04T15:32:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/horizon-to-acquire-gene-tech-business-dharmacon-from-ge-200717-5876593/</loc>
		<lastmod>2018-07-04T15:32:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emergent-biosolutions-to-buy-gsks-anthrax-treatment-raxibacumab-200717-5875921/</loc>
		<lastmod>2018-07-04T15:32:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c64b3mortara_extends_ecg_warehouse_crada_wit/</loc>
		<lastmod>2018-07-04T15:32:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/57495sirius_genomics_names_three_new_board_me/</loc>
		<lastmod>2018-07-04T15:32:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/21491harvard_bioscience_names_ne/</loc>
		<lastmod>2018-07-04T15:32:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/acute-myeloid-leukemia-market-to-cross-15bn-by-2026-says-globaldata-190717-5875212/</loc>
		<lastmod>2018-07-04T15:32:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c84bbpatheon_and_solvias_partner_to_offer_integrated_development_ser/</loc>
		<lastmod>2018-07-04T15:32:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4748fsolos_endoscopy_introduces_mammo_view_system_in_puerto/</loc>
		<lastmod>2018-07-04T15:32:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/prana-takeda-to-research-on-treating-parkinsons-disease-gastrointestinal-neuropathology-190717-5875190/</loc>
		<lastmod>2018-07-04T15:32:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sarepta-biomarin-settle-patent-litigation-over-dmd-exon-skipping-drugs-190717-5875159/</loc>
		<lastmod>2018-07-04T15:32:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-gileads-vosevi-to-re-treat-hcv-infection-in-adults-190717-5874711/</loc>
		<lastmod>2018-07-04T15:32:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chmp-issues-positive-opinion-for-daiichi-sankyos-lixiana-label-update-180717-5873556/</loc>
		<lastmod>2018-07-04T15:32:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/valeant-to-divest-obagi-medical-products-business-180717-5873534/</loc>
		<lastmod>2018-07-04T15:32:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/374bajavelin_pharmaceuticals_to_reduce_workforce_b/</loc>
		<lastmod>2018-07-04T15:32:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1b48canaspec_opens_new_gmp_manufacturing_fac/</loc>
		<lastmod>2018-07-04T15:32:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3e498joshua_partners_acquires_me/</loc>
		<lastmod>2018-07-04T15:32:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/674a1stereotaxis_to_launch_magnetic_irrigated_catheter_in_e/</loc>
		<lastmod>2018-07-04T15:32:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fd486icon_acquires_prevalere_life_sci/</loc>
		<lastmod>2018-07-04T15:32:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-rejects-amgens-bla-for-osteoporosis-treatment-evenity-180717-5873275/</loc>
		<lastmod>2018-07-04T15:32:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sunovion-to-sell-asthma-and-allergy-products-to-covis-170717-5872284/</loc>
		<lastmod>2018-07-04T15:32:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uk-government-grants-over-120m-for-global-health-research-170717-5872275/</loc>
		<lastmod>2018-07-04T15:32:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cb4a0proteome_systems_changes_name_to_tyrian_diagno/</loc>
		<lastmod>2018-07-04T15:32:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3c487valeant_pharmaceuticals_acquires_derm/</loc>
		<lastmod>2018-07-04T15:32:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b48ezynex_wins_ce_mark_for_two_new_pain_management_de/</loc>
		<lastmod>2018-07-04T15:32:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e7485eisai_wins_fda_approval_for_seizure/</loc>
		<lastmod>2018-07-04T15:32:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/734b6biodel_reports_positive_effects_of_viaject_insulin_in_diabetes_pat/</loc>
		<lastmod>2018-07-04T15:32:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mayo-nference-create-startup-to-develop-drugs-for-rare-diseases-170717-5872213/</loc>
		<lastmod>2018-07-04T15:32:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emergent-biosolutions-to-buy-sanofis-smallpox-vaccine-business-for-125m-170717-5871956/</loc>
		<lastmod>2018-07-04T15:32:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biognosys-secures-funding-to-develop-proteomics-140717-5871130/</loc>
		<lastmod>2018-07-04T15:32:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7d480teleflex_signs_new_respiratory_care_agreement_with_health/</loc>
		<lastmod>2018-07-04T15:32:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0b48fmeda_signs_agreement_with_uluru_for_amlexanox_5_paste_and_orad/</loc>
		<lastmod>2018-07-04T15:32:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/524b3admetrx_and_roche_form_collabor/</loc>
		<lastmod>2018-07-04T15:32:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ff490zoll_signs_purchasing_agreement_with_health/</loc>
		<lastmod>2018-07-04T15:32:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bb49bcuriss_collaborator_genentech_grants_exus_rights_of_cancer_drug_to_/</loc>
		<lastmod>2018-07-04T15:32:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/puretechs-alv-107-shown-to-control-pain-longer-than-lidocaine-140717-5871122/</loc>
		<lastmod>2018-07-04T15:32:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/kyprolis-regimen-improves-survival-rate-in-amgens-phase-3-myeloma-trial-140717-5871092/</loc>
		<lastmod>2018-07-04T15:32:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jjs-janssen-biotech-gets-fda-nod-for-tremfya-to-treat-plaque-psoriasis-140717-5870721/</loc>
		<lastmod>2018-07-04T15:32:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3a48ftheraquests_ind_for_abuse_deterrent_opioid_accepted_b/</loc>
		<lastmod>2018-07-04T15:32:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/464b0watsons_trelstar_nda_accepted_for_filing_b/</loc>
		<lastmod>2018-07-04T15:32:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8c4b5bioforce_nanosciences_signs_collaboration_agreement_with_upmc_and/</loc>
		<lastmod>2018-07-04T15:32:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8a498amags_ferumoxytol_resubmission_designated_complete_class_1_response_b/</loc>
		<lastmod>2018-07-04T15:32:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec4abzoll_and_masimo_sign_technology_agre/</loc>
		<lastmod>2018-07-04T15:32:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lilly-to-settle-us-cialis-patent-litigation-130717-5869713/</loc>
		<lastmod>2018-07-04T15:32:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/erytech-queens-university-to-advance-eryminase-program-130717-5869701/</loc>
		<lastmod>2018-07-04T15:32:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-advisory-committee-recommends-novartis-ctl019-for-rr-b-cell-all-130717-5869427/</loc>
		<lastmod>2018-07-04T15:32:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6e4a1genetic_immunity_initiates_dosing_for_phase_ii_hiv_/</loc>
		<lastmod>2018-07-04T15:32:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1849dsigmaaldrich_signs_distribution_agreement_with_alpha/</loc>
		<lastmod>2018-07-04T15:32:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/084baredpoint_bio_signs_pharmaceutical_research_agreement_with_sch/</loc>
		<lastmod>2018-07-04T15:32:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/874bechina_sky_one_medical_wins_production_rights_for_nine_new_/</loc>
		<lastmod>2018-07-04T15:32:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-advisory-panel-recommends-pfizers-mylotarg-for-acute-myeloid-leukemia-120717-5868269/</loc>
		<lastmod>2018-07-04T15:32:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amicus-to-submit-nda-in-us-for-migalastat-for-fabry-disease-120717-5868319/</loc>
		<lastmod>2018-07-04T15:32:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-max-planck-and-lead-discovery-enter-into-cancer-research-collaboration-120717-5868301/</loc>
		<lastmod>2018-07-04T15:32:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-to-buy-us-vaccines-biotechnology-firm-protein-sciences-120717-5868170/</loc>
		<lastmod>2018-07-04T15:32:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/broad-institute-of-mit-and-harvard-enters-discussions-to-form-global-crispr-cas9-licensing-pool-110717-5867029/</loc>
		<lastmod>2018-07-04T15:32:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0f4addelphi_genetics_signs_collaboration_agreement_with_eurogentec_biol/</loc>
		<lastmod>2018-07-04T15:32:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d5494theratechnologies_completes_phase_iii_hivassociated_lipodystrophy_/</loc>
		<lastmod>2018-07-04T15:32:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/974b2wyeth_wins_fda_approval_for_new_indication_of_premarin_vaginal_/</loc>
		<lastmod>2018-07-04T15:32:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/abpi-applies-for-judicial-review-against-new-procedures-for-cost-effective-medicines-1107117-5867016/</loc>
		<lastmod>2018-07-04T15:32:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/524bfinotek_pharmaceuticals_granted_two_new_us_pa/</loc>
		<lastmod>2018-07-04T15:32:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/584acperrigo_acquires_unico_hol/</loc>
		<lastmod>2018-07-04T15:32:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-bms-snda-to-review-sprycel-in-philadelphia-cp-cml-110717-5866184/</loc>
		<lastmod>2018-07-04T15:32:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/elite-to-pause-pain-relief-drug-sequestoxs-clinical-trials-100717-5865712/</loc>
		<lastmod>2018-07-04T15:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lilly-wins-alimta-vitamin-regimen-patent-case-in-uk-supreme-court-100717-5865685/</loc>
		<lastmod>2018-07-04T15:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e64afchelsea_initiates_dosing_for_phase_i_study_of_antiinflammatory/</loc>
		<lastmod>2018-07-04T15:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6c499lexicon_pharmaceuticals_completes_phase_i_carcinoid_syndrome_/</loc>
		<lastmod>2018-07-04T15:33:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6c4b3medtronic_acquires_cryocath_technol/</loc>
		<lastmod>2018-07-04T15:33:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a0491cvbt_signs_clinical_development_agreement_with_cardio_neoge/</loc>
		<lastmod>2018-07-04T15:33:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fb48fmedimmune_names_new_pres/</loc>
		<lastmod>2018-07-04T15:33:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shield-ewopharma-partner-on-feraccru-in-switzerland-100717-5865696/</loc>
		<lastmod>2018-07-04T15:33:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alnylam-sanofi-genzyme-begin-clinical-trial-program-of-hemophilia-treatment-fitusiran-100717-5865331/</loc>
		<lastmod>2018-07-04T15:33:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/entasis-garp-to-initiate-pivotal-trials-of-gonorrhea-drug-zoliflodacin-070717-5864552/</loc>
		<lastmod>2018-07-04T15:33:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3b4b3bayer_pledges_e15_million_support_for_hemophilia_treatment_centers_in_/</loc>
		<lastmod>2018-07-04T15:33:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bc486ambrx_announces_positive_data_from_phase_iii_aghd_/</loc>
		<lastmod>2018-07-04T15:33:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/26487thrombogenics_announces_six_month_results_of_phase_iib_visual_disorders_/</loc>
		<lastmod>2018-07-04T15:33:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c34bcpfizer_reports_positive_findings_from_subanalysis_of_lipitor_/</loc>
		<lastmod>2018-07-04T15:33:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6f49aintelect_medical_closes_financing_deal_with_boston_scientific_and_great/</loc>
		<lastmod>2018-07-04T15:33:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire-submits-ind-for-hemophilia-a-treatment-in-us-070717-5864243/</loc>
		<lastmod>2018-07-04T15:33:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biohavens-bhv-5000-secures-fda-orphan-drug-designation-for-rett-syndrome-070717-5864360/</loc>
		<lastmod>2018-07-04T15:33:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-tonixs-proposed-brand-name-for-tnx-102-sl-070717-5864380/</loc>
		<lastmod>2018-07-04T15:33:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cb492quigley_pharma_to_complete_phase_iib_diabetic_peripheral_neuropathy_/</loc>
		<lastmod>2018-07-04T15:33:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/944bcmarshall_edwardss_phase_iii_ovarian_cancer_trial_wins_positive_r/</loc>
		<lastmod>2018-07-04T15:33:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b490ferring_names_new_vice_president_of_orthopedics_and_urology_business/</loc>
		<lastmod>2018-07-04T15:33:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7f482nyer_medicals_subsidiary_signs_pharmacy_service_agre/</loc>
		<lastmod>2018-07-04T15:33:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2848eupmc_and_ge_healthcare_partner_to_develop_international_oncology_ce/</loc>
		<lastmod>2018-07-04T15:33:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/prothena-commences-phase-2-trial-of-parkinsons-disease-drug-060717-5863140/</loc>
		<lastmod>2018-07-04T15:33:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/auris-medical-finishes-enrolling-for-phase-3-trial-of-am-111-in-deaf-patients-060717-5863078/</loc>
		<lastmod>2018-07-04T15:33:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celgene-beigene-to-advance-pd-1-inhibitor-for-solid-tumor-cancers-060717-5863041/</loc>
		<lastmod>2018-07-04T15:33:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/34494diamyd_medical_announces_european_patent_for_treatment_of_erectile_dysfun/</loc>
		<lastmod>2018-07-04T15:33:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c4483astrazenecas_seroquel_wins_european_approval_for_new_indica/</loc>
		<lastmod>2018-07-04T15:33:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8d4a0icon_establishes_new_facility_in_/</loc>
		<lastmod>2018-07-04T15:33:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8348dacorda_names_new_chief_medical_of/</loc>
		<lastmod>2018-07-04T15:33:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-places-clinical-hold-on-mercks-three-blood-cancer-trials-060717-5862620/</loc>
		<lastmod>2018-07-04T15:33:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fc491basileas_new_antimrsa_antibiotic_wins_swiss_app/</loc>
		<lastmod>2018-07-04T15:33:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alexion-signs-funding-deal-with-nice-and-nhs-england-for-strensiq-050717-5861723/</loc>
		<lastmod>2018-07-04T15:33:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/zealand-pharma-starts-phase-3-trial-of-dasiglucagon-to-treat-severe-hypoglycemia-in-diabetes-050717-5861709/</loc>
		<lastmod>2018-07-04T15:33:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/98495gsk_commences_tender_offer_to_acquire_genelabs_technolog/</loc>
		<lastmod>2018-07-04T15:33:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/974b1cvs_caremark_names_new_executive_vice_president_and_chief_medical_of/</loc>
		<lastmod>2018-07-04T15:33:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ee4b3pharmavigilant_launches_electronic_capture_database_for_phase_iii_cancer_/</loc>
		<lastmod>2018-07-04T15:33:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c84aaaeterna_zentaris_to_sell_cetrotide_royalty_stream_to/</loc>
		<lastmod>2018-07-04T15:33:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sun-pharma-samsung-biologics-sign-manufacturing-deal-for-psoriasis-drug-tildrakizumab-050717-5861394/</loc>
		<lastmod>2018-07-04T15:33:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/biomarin-submits-pegvaliase-bla-to-fda-for-treatment-of-phenylketonuria-040717-5860397/</loc>
		<lastmod>2018-07-04T15:33:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fe485k2m_acquires_rights_to_psds_injectable_polymer_techn/</loc>
		<lastmod>2018-07-04T15:33:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/japans-mhlw-approves-olumiant-to-treat-rheumatoid-arthritis-040717-5860386/</loc>
		<lastmod>2018-07-04T15:33:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-enters-into-drug-discovery-collaboration-with-exscientia-040716-5859958/</loc>
		<lastmod>2018-07-04T15:33:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-triptodur-to-treat-central-precocious-puberty-030717-5859075/</loc>
		<lastmod>2018-07-04T15:33:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/european-commission-approves-pfizers-hard-to-treat-leukemia-drug-besponsa-030717-5859057/</loc>
		<lastmod>2018-07-04T15:33:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/db4a3torreypines_therapeutics_names_ne/</loc>
		<lastmod>2018-07-04T15:33:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c04acmetabolex_reports_positive_results_from_phase_ia_study_of_diabetes/</loc>
		<lastmod>2018-07-04T15:33:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/71484amedica_wins_ce_mark_for_valeo_ceramic_spinal_implant_s/</loc>
		<lastmod>2018-07-04T15:33:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4b4b4octoplus_obtains_new_drug_delivery_evaluation_con/</loc>
		<lastmod>2018-07-04T15:33:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/73488phosphagenics_initiates_phase_i_study_of_antiinflammatory/</loc>
		<lastmod>2018-07-04T15:33:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-pain-drug-mirogabalin-meets-primary-end-point-in-neucourse-phase-3-study-030716-5858590/</loc>
		<lastmod>2018-07-04T15:33:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f049bbiolinerx_and_yissum_sign_licensing_agre/</loc>
		<lastmod>2018-07-04T15:33:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d04a2china_medical_wins_approval_for_breast_cancer_her2_fish_/</loc>
		<lastmod>2018-07-04T15:33:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cytomx-advances-cd71-targeting-probody-drug-conjugate-300617-5857478/</loc>
		<lastmod>2018-07-04T15:33:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/servier-transgene-to-research-on-viral-vectorization-technology-for-allogenic-car-t-300617-5857473/</loc>
		<lastmod>2018-07-04T15:33:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6d4aeantyra_signs_licensing_agreement_with_novo_no/</loc>
		<lastmod>2018-07-04T15:33:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e84b9athersys_achieves_milestone_in_bristolmyers_squibb_discovery_all/</loc>
		<lastmod>2018-07-04T15:33:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chi-med-astrazeneca-initiate-phase-3-prcc-trial-of-cancer-drug-savolitinib-300617-5857466/</loc>
		<lastmod>2018-07-04T15:33:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec-approves-expanded-use-of-novartis-lung-cancer-treatment-zykadi-300617-5857034/</loc>
		<lastmod>2018-07-04T15:33:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lifearc-dstl-cdrd-to-research-on-antibacterial-drug-targets-290617-5855872/</loc>
		<lastmod>2018-07-04T15:33:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b64a9portola_reports_encouraging_results_from_antiplatelet_drug_/</loc>
		<lastmod>2018-07-04T15:33:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9a4bfviropharma_reports_encouraging_data_from_study_of_angioedema/</loc>
		<lastmod>2018-07-04T15:33:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8a4b0mannatechs_coo_to_r/</loc>
		<lastmod>2018-07-04T15:33:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/de4bdzabecors_ind_application_for_asthma_drug_wins_fda_app/</loc>
		<lastmod>2018-07-04T15:33:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aa4a4ensemble_discovery_extends_collaboration_agreement_with_/</loc>
		<lastmod>2018-07-04T15:33:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mercks-reveal-study-of-anacetrapib-meets-primary-endpoint-290617-5855946/</loc>
		<lastmod>2018-07-04T15:33:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/cancer-drugs-funds-helps-nhs-patients-with-early-access-to-new-cancer-drugs-290617-5855928/</loc>
		<lastmod>2018-07-04T15:33:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-implements-two-new-measures-to-increase-drug-competition-290617-5855524/</loc>
		<lastmod>2018-07-04T15:33:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/094a5nymox_reports_new_positive_results_from_benign_prostatic_hyperplasia_/</loc>
		<lastmod>2018-07-04T15:33:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/90480etrials_worldwide_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:33:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/18497raptor_reports_promising_results_from_phase_iia_aldh2_deficiency_/</loc>
		<lastmod>2018-07-04T15:33:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/36486accumetrics_names_new_chief_medical_of/</loc>
		<lastmod>2018-07-04T15:33:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8f491alexions_president_to_r/</loc>
		<lastmod>2018-07-04T15:33:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arix-bioscience-buys-stake-in-mitoconix-bio-280617-5854501/</loc>
		<lastmod>2018-07-04T15:33:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-begins-construction-of-new-rd-facility-in-missouri-280617-5854479/</loc>
		<lastmod>2018-07-04T15:33:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-etanercept-biosimilar-approved-in-europe-to-treat-inflammatory-diseases-280617-5854460/</loc>
		<lastmod>2018-07-04T15:33:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/214b8alba_therapeutics_initiates_enrollment_in_phase_iib_celiac_disease_/</loc>
		<lastmod>2018-07-04T15:33:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e54a1ekr_therapeutics_wins_fda_approval_for_double_concentration_premixed_iv/</loc>
		<lastmod>2018-07-04T15:33:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/904b5genvecs_tnferade_wins_fast_track_designation_for_pancreatic_cancer_trea/</loc>
		<lastmod>2018-07-04T15:33:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ce485intellect_validates_european_patent_for_alzheimers_antibody_pla/</loc>
		<lastmod>2018-07-04T15:33:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f0485oit_acquires_toshiba_aplio_artida_4d_ultrasound_s/</loc>
		<lastmod>2018-07-04T15:33:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7b49cscs_licenses_its_stem_cell_technology_for_pharmaceutical_res/</loc>
		<lastmod>2018-07-04T15:33:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7e4a9irvine_pharmaceutical_services_to_launch_avrio_biopharmaceut/</loc>
		<lastmod>2018-07-04T15:33:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ca4a9cell_therapeuticss_phase_iii_lymphoma_trial_meets_primary_end/</loc>
		<lastmod>2018-07-04T15:33:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b2495imclone_initiates_enrollment_in_phase_ii_lung_cancer_/</loc>
		<lastmod>2018-07-04T15:33:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2c4a3haptoglobin_genotype_testing_plays_key_role_in_diabetes_therapy_says_syn/</loc>
		<lastmod>2018-07-04T15:33:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ed497cynvec_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:33:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b7493cytrx_reports_encouraging_results_from_phase_i_leukemia_/</loc>
		<lastmod>2018-07-04T15:33:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9e485compugen_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:33:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2448cnovexel_initiates_phase_ii_urinary_tract_infections_/</loc>
		<lastmod>2018-07-04T15:33:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2c4aamarillion_and_bracco_imaging_sign_licensing_agre/</loc>
		<lastmod>2018-07-04T15:33:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5f483biovitrum_and_wyeth_extend_supply_agre/</loc>
		<lastmod>2018-07-04T15:33:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9d4aasanofis_polio_vaccine_selected_for_immunization_program_in_r/</loc>
		<lastmod>2018-07-04T15:33:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7348clipocine_establishes_clinical_feasibility_of_psychiatric/</loc>
		<lastmod>2018-07-04T15:33:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8f4a7sanofiaventis_presents_positive_data_from_atrial_fibrillation_/</loc>
		<lastmod>2018-07-04T15:33:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e049fsanofi_pasteur_enters_japanese_pediatric_vaccine_m/</loc>
		<lastmod>2018-07-04T15:33:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6e4a2colorcon_establishes_new_west_coast_fac/</loc>
		<lastmod>2018-07-04T15:33:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4549ecelldex_signs_licensing_agreement_with_university_of_southampto/</loc>
		<lastmod>2018-07-04T15:33:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b44a0remote_monitoring_of_icds_more_effective_says_biot/</loc>
		<lastmod>2018-07-04T15:33:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/73484affymetrix_to_acquire_pan/</loc>
		<lastmod>2018-07-04T15:33:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cf4b7great_basin_scientific_names_new_vice_president_of_opera/</loc>
		<lastmod>2018-07-04T15:33:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/494bechf_solutions_signs_agreement_with_premier_purchasing_par/</loc>
		<lastmod>2018-07-04T15:34:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5748abiotrove_and_constellation_pharmaceuticals_form_research_collaborat/</loc>
		<lastmod>2018-07-04T15:34:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/26482palomar_medical_and_reliant_technologies_launch/</loc>
		<lastmod>2018-07-04T15:34:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5f493nitric_biotherapeutics_names_ne/</loc>
		<lastmod>2018-07-04T15:34:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d04a2accera_raises_35_million_in_series_c_fina/</loc>
		<lastmod>2018-07-04T15:34:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a34b6novartiss_tekturna_found_to_be_effective_against_high_blood_pre/</loc>
		<lastmod>2018-07-04T15:34:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b349bgsk_to_close_dartford_fac/</loc>
		<lastmod>2018-07-04T15:34:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f049eqiagen_launches_new_molecular_/</loc>
		<lastmod>2018-07-04T15:34:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0c4betargeted_genetics_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:34:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8a491gsk_and_xenoport_withdraw_new_drug_application_for_rls/</loc>
		<lastmod>2018-07-04T15:34:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dd49btorreypines_sells_alzheimers_disease_genetics_program_to_/</loc>
		<lastmod>2018-07-04T15:34:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c1480boston_scientific_wins_fda_approval_for_apex_ptca_dilatation_cathe/</loc>
		<lastmod>2018-07-04T15:34:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/144bfadeona_granted_new_us_patent_for_oral_tiomolibdate_diamm/</loc>
		<lastmod>2018-07-04T15:34:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b2487azur_pharma_and_elan_collaborate_to_develop_oncedaily_cloz/</loc>
		<lastmod>2018-07-04T15:34:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b4afintegrated_biopharma_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:34:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/894bbpharmasset_announces_initiation_of_hepatitis_antiviral_combination_/</loc>
		<lastmod>2018-07-04T15:34:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/074b8celgene_wins_fda_clearance_for_phase_i_placentaderived_stem_cell_/</loc>
		<lastmod>2018-07-04T15:34:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/41484arbor_vita_signs_collaboration_and_licensing_agreement_wi/</loc>
		<lastmod>2018-07-04T15:34:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f14a4xoma_restructures_drug_development_collaboration_with_nov/</loc>
		<lastmod>2018-07-04T15:34:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7c4a5nupathe_names_new_vice_president_an/</loc>
		<lastmod>2018-07-04T15:34:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3949fadvinus_therapeutics_launches_us_opera/</loc>
		<lastmod>2018-07-04T15:34:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fa48camylin_announces_restructuring_cuts_340/</loc>
		<lastmod>2018-07-04T15:34:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a9493lorus_completes_indenabling_toxicology_studies_for_cancer/</loc>
		<lastmod>2018-07-04T15:34:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/98484anesivas_pain_drug_fails_endpoint_in_phase_iii_/</loc>
		<lastmod>2018-07-04T15:34:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b64933sbio_files_for_chinese_approval_of_kidney_cancer/</loc>
		<lastmod>2018-07-04T15:34:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/474abkamada_signs_supply_agreement_with_multinational_comp/</loc>
		<lastmod>2018-07-04T15:34:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/df4a4sangamo_reports_topline_data_from_phase_ii_diabetic_neuropathy_tr/</loc>
		<lastmod>2018-07-04T15:34:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bb498endocare_and_galil_medical_sign_merger_agre/</loc>
		<lastmod>2018-07-04T15:34:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8a4bcarqule_and_daiichisankyo_form_rd_partnership_for_cancer_drug_develo/</loc>
		<lastmod>2018-07-04T15:34:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0c4a3precision_therapeutics_raises_43_million_in_fina/</loc>
		<lastmod>2018-07-04T15:34:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/09495sciencebased_health_introduces_new_dietary_supplement_for_dia/</loc>
		<lastmod>2018-07-04T15:34:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cc4a3cepheid_introduces_new_molecular_diagnostic_test_in_e/</loc>
		<lastmod>2018-07-04T15:34:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f3487stem_cell_sciences_signs_services_agreement_with_chdi_found/</loc>
		<lastmod>2018-07-04T15:34:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e34abpsyadon_secures_8_million_in_fina/</loc>
		<lastmod>2018-07-04T15:34:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/794b2entremeds_phase_iii_lung_cancer_study_meets_end/</loc>
		<lastmod>2018-07-04T15:34:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/934bborexigen_names_new_executive_chairman_and_interi/</loc>
		<lastmod>2018-07-04T15:34:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a44bboptimer_reports_positive_results_from_phase_iii_cdi_/</loc>
		<lastmod>2018-07-04T15:34:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9f4a0clinical_data_introduces_new_genetic/</loc>
		<lastmod>2018-07-04T15:34:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a0499immunogen_names_new_vice_president_and_chief_medical_of/</loc>
		<lastmod>2018-07-04T15:34:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3a48eosmetech_initiates_clinical_studies_for_new_warfarin_sensitivity/</loc>
		<lastmod>2018-07-04T15:34:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b34b1critical_pharmaceuticals_raises_gbp650000_in_fina/</loc>
		<lastmod>2018-07-04T15:34:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c64b7ophthotech_initiates_treatment_in_phase_i_wet_amd_/</loc>
		<lastmod>2018-07-04T15:34:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/41494potentia_reports_positive_data_from_phase_i_amd_/</loc>
		<lastmod>2018-07-04T15:34:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/90487avis_partner_global_therapeutics_initiates_study_of_new_drug_eluting_/</loc>
		<lastmod>2018-07-04T15:34:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/224bfeyegate_pharma_initiates_enrollment_in_phase_ii_dry_eye_/</loc>
		<lastmod>2018-07-04T15:34:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1a4b7duska_and_dsm_pharmaceuticals_partner_to_manufacture_psvt_drug_pr/</loc>
		<lastmod>2018-07-04T15:34:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/53480zynex_wins_ce_marking_for_neuromove_and_truwave_de/</loc>
		<lastmod>2018-07-04T15:34:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ba491astrazenecas_crestor_reduces_cardiovascular_risk_in_statin_outcomes_/</loc>
		<lastmod>2018-07-04T15:34:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sanofi-regeneron-secure-ec-approval-for-kevzara-to-treat-rheumatoid-arthritis-280617-5854119/</loc>
		<lastmod>2018-07-04T15:34:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/234bfcnsystems_medizintechnik_wins_fda_clearance_for_cnap_monito/</loc>
		<lastmod>2018-07-04T15:34:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/084a1nanogen_partners_with_menarini_for_marketing_ivd_infectious_disease/</loc>
		<lastmod>2018-07-04T15:34:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bluebird-bios-phase-23-study-of-lenti-d-gene-therapy-yields-positive-results-270617-5853282/</loc>
		<lastmod>2018-07-04T15:34:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-nda-filing-for-icons-dexycu-270617-5853274/</loc>
		<lastmod>2018-07-04T15:34:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/904a1diagenic_introduces_first_breast_cancer_geneexpression_blood/</loc>
		<lastmod>2018-07-04T15:34:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/37481raptor_partners_with_chu_dangers_for_phase_ii_huntingtons_disease_/</loc>
		<lastmod>2018-07-04T15:34:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e5490via_pharmaceuticals_reports_positive_data_from_phase_ii_cardiovascular_st/</loc>
		<lastmod>2018-07-04T15:34:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c9486vertos_medical_names_new_president_and_ceo_expands_/</loc>
		<lastmod>2018-07-04T15:34:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches-haemophilia-a-drug-emicizumab-shows-significant-effect-in-phase-iii-studies-270617-5853000/</loc>
		<lastmod>2018-07-04T15:34:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/emas-chmp-recommends-samsung-bioepis-imraldi-for-ec-approval-260617-5852469/</loc>
		<lastmod>2018-07-04T15:34:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a4a0acologix_presents_positive_data_from_preclinical_studies_o/</loc>
		<lastmod>2018-07-04T15:34:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-gets-crl-on-epogen-biosimilar-from-fda-230617-5851688/</loc>
		<lastmod>2018-07-04T15:34:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/repare-therapeutics-secures-68m-funding-230617-5851836/</loc>
		<lastmod>2018-07-04T15:34:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lilly-expands-san-diego-biotechnology-center-in-us-230617-5851822/</loc>
		<lastmod>2018-07-04T15:34:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-heart-drug-canakinumab-meets-primary-endpoint-in-phase-iii-study-230617-5851543/</loc>
		<lastmod>2018-07-04T15:34:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ad485icos_oral_amphotericin_b_found_to_be_effective_against_leishman/</loc>
		<lastmod>2018-07-04T15:34:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4e487bioreliance_launches_new_protein_array_pla/</loc>
		<lastmod>2018-07-04T15:34:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0c496smith__nephew_launches_acticoat/</loc>
		<lastmod>2018-07-04T15:34:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/78495takeda_wins_key_ruling_against_teva_over_generic_heartburn/</loc>
		<lastmod>2018-07-04T15:34:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/974a1innexus_biotechnology_announces_development_of_new_colorectal_cancer/</loc>
		<lastmod>2018-07-04T15:34:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/dc4a6competitive_technologies_signs_distribution_agreement_with_ag_healt/</loc>
		<lastmod>2018-07-04T15:34:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/884afwinston_laboratories_signs_licensing_agreement_with_sanofiaventis_c/</loc>
		<lastmod>2018-07-04T15:34:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/91491applied_biosystems_and_asuragen_form_collaboration_with_c/</loc>
		<lastmod>2018-07-04T15:34:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsks-shingles-vaccine-shingrix-succeeds-in-phase-3-revaccination-trial-220617-5850201/</loc>
		<lastmod>2018-07-04T15:34:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/524a2onyx_licenses_cancer_compound_from_btg_internat/</loc>
		<lastmod>2018-07-04T15:34:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0a48bclx_medical_amends_purchasing_agreement_for_thyrotest_rapid_screening_d/</loc>
		<lastmod>2018-07-04T15:34:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immunocellular-to-suspend-patient-randomization-for-ict-107-phase-3-trial-220617-5850245/</loc>
		<lastmod>2018-07-04T15:34:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/rubius-therapeutics-raises-120m-in-new-funding-round-220617-5850233/</loc>
		<lastmod>2018-07-04T15:34:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b34a1integrated_genomics_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:34:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire-gets-fda-approval-for-adhd-treatment-mydayis-220617-5850078/</loc>
		<lastmod>2018-07-04T15:34:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/effector-to-partner-with-pfizer-merck-on-immune-oncology-combination-210617-5849060/</loc>
		<lastmod>2018-07-04T15:34:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1f484affymax_reports_positive_results_from_phase_ii_anemia_/</loc>
		<lastmod>2018-07-04T15:34:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/09492spectrum_pharmaceuticals_wins_415_million_payment_from_all/</loc>
		<lastmod>2018-07-04T15:34:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cb498aldagen_and_uc_davis_form_collabor/</loc>
		<lastmod>2018-07-04T15:34:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biondvax-secures-eib-loan-to-develop-universal-flu-vaccine-210617-5849046/</loc>
		<lastmod>2018-07-04T15:34:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9d4a1patheon_opens_new_european_headquarters_in_switze/</loc>
		<lastmod>2018-07-04T15:34:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/444aagsk_to_reduce_us_sales_jobs_by_/</loc>
		<lastmod>2018-07-04T15:34:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c94bbnovo_nordisk_invests_400_million_in_chinese_insulin_production_/</loc>
		<lastmod>2018-07-04T15:34:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/414b0aegerion_presents_positive_results_from_phase_ii_studies_of_dyslipidemia/</loc>
		<lastmod>2018-07-04T15:34:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pamplona-to-buy-us-firm-parexel-international-for-5bn-210617-5848614/</loc>
		<lastmod>2018-07-04T15:34:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/seattle-genetics-scraps-leukemia-drug-trial-over-safety-concerns-200617-5847727/</loc>
		<lastmod>2018-07-04T15:34:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-initiates-phase-1-study-of-streptococcus-vaccine-200617-5847803/</loc>
		<lastmod>2018-07-04T15:34:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c64a2nomir_medical_wins_european_patent_on_noveon_techn/</loc>
		<lastmod>2018-07-04T15:34:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5549dgenentech_osi_pharmaceuticals_report_positive_phase_iii_cancer_study_re/</loc>
		<lastmod>2018-07-04T15:35:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/axovants-dementia-drug-granted-fda-fast-track-designation-200617-5847781/</loc>
		<lastmod>2018-07-04T15:35:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sandoz-gets-ec-nod-for-rixathon-to-treat-blood-cancers-and-immunological-diseases-200617-5847575/</loc>
		<lastmod>2018-07-04T15:35:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/adamis-epinephrine-pre-filled-syringe-secures-fda-approval-190617-5846562/</loc>
		<lastmod>2018-07-04T15:35:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/26480poniard_announces_positive_topline_results_from_phase_i_study_of_tumor/</loc>
		<lastmod>2018-07-04T15:35:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/78494amdl_names_new_coo_expands_management/</loc>
		<lastmod>2018-07-04T15:35:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a54b8wuxi_pharmatech_signs_new_collaboration_agreement_with_p/</loc>
		<lastmod>2018-07-04T15:35:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2f4b2salient_surgical_technologies_names_new_board_m/</loc>
		<lastmod>2018-07-04T15:35:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/db4a3repligen_initiates_phase_iib_bipolar_depression_/</loc>
		<lastmod>2018-07-04T15:35:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/774b9invitrogen_introduces_new_microarray_for_studying_noncodin/</loc>
		<lastmod>2018-07-04T15:35:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6a493prostrakan_signs_licensing_agreement_with_newbridge_pharmaceut/</loc>
		<lastmod>2018-07-04T15:35:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-to-divest-irish-facility-to-sk-biotek-190617-5846543/</loc>
		<lastmod>2018-07-04T15:35:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/fda-extends-dysport-use-for-lower-limb-spasticity-in-adults-190617-5846572/</loc>
		<lastmod>2018-07-04T15:35:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-cosentyx-delivers-positive-results-for-ankylosing-spondylitis-and-psoriatic-arthritis-160617-5845087/</loc>
		<lastmod>2018-07-04T15:35:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/62481plethoras_european_phase_iii_premature_ejaculation_study_meets_end/</loc>
		<lastmod>2018-07-04T15:35:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/114a0bioheart_obtains_notice_of_allowance_for_nine_new_patent_c/</loc>
		<lastmod>2018-07-04T15:35:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immune-agrees-to-regain-worldwide-rights-for-ceplene-160617-5845169/</loc>
		<lastmod>2018-07-04T15:35:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/basilea-pfizer-enter-license-agreement-for-cresemba-in-select-regions-160617-5845159/</loc>
		<lastmod>2018-07-04T15:35:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nice-approves-roches-breast-cancer-drug-kadcyla-for-routine-use-160617-5845139/</loc>
		<lastmod>2018-07-04T15:35:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1b4bcangiodynamics_to_launch_new_varicose_vein_therapy_/</loc>
		<lastmod>2018-07-04T15:35:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/91483global_meds_subsidiary_licenses_laboratory_software_to_gabriel_martin_hos/</loc>
		<lastmod>2018-07-04T15:35:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4748cpar_pharmaceutical_begins_shipment_of_generic_imitrex_inje/</loc>
		<lastmod>2018-07-04T15:35:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ad481daiichi_sankyo_completes_purchase_of_stake_in_ra/</loc>
		<lastmod>2018-07-04T15:35:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/584b6cutispharma_receives_new_patent_for_suppository_compou/</loc>
		<lastmod>2018-07-04T15:35:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/accenture-1qbit-work-with-biogen-to-speed-up-drug-discovery-with-quantum-computing-150617-5843835/</loc>
		<lastmod>2018-07-04T15:35:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/domainex-imperial-college-expand-partnership-on-therapies-to-reduce-heart-muscle-damage-150617-5843824/</loc>
		<lastmod>2018-07-04T15:35:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jsr-life-sciences-to-buy-cell-line-generation-technologies-provider-selexis-150617-5843763/</loc>
		<lastmod>2018-07-04T15:35:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/omeros-masp-2-inhibitor-gets-fda-breakthrough-therapy-designation-for-iga-nephropathy-140617-5842592/</loc>
		<lastmod>2018-07-04T15:35:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-lilly-get-fda-fast-track-status-for-chronic-pain-drug-tanezumab-140617-5842234/</loc>
		<lastmod>2018-07-04T15:35:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/centrexions-pain-drug-cntx-4975-yields-positive-results-in-phase-2b-knee-osteoarthritis-trial-140617-5842607/</loc>
		<lastmod>2018-07-04T15:35:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/964b5cv_therapeuticss_ranexa_wins_fda_approval_for_first_line_antiangina/</loc>
		<lastmod>2018-07-04T15:35:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/67493morria_reports_positive_results_from_phase_ii_allergic_rhinitis_/</loc>
		<lastmod>2018-07-04T15:35:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a44bbakela_pharma_announces_key_management_chan/</loc>
		<lastmod>2018-07-04T15:35:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/444b5bilcare_expands_preclinical_and_earlystage_development_capabil/</loc>
		<lastmod>2018-07-04T15:35:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c64afanamar_medical_secures_sek75_million_in_new_fina/</loc>
		<lastmod>2018-07-04T15:35:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/remds-lead-candidate-succeeds-in-phase-1-trial-in-type-1-diabetes-patients-140617-5842621/</loc>
		<lastmod>2018-07-04T15:35:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/selexis-teneobio-to-advance-uniabs-development-for-cancer-treatment-130617-5841398/</loc>
		<lastmod>2018-07-04T15:35:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/numerate-takeda-to-use-ai-driven-drug-discovery-for-generating-novel-candidates-130617-5841374/</loc>
		<lastmod>2018-07-04T15:35:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/df484cabernet_and_eli_lilly_form_pharmacogenetics_all/</loc>
		<lastmod>2018-07-04T15:35:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d84b3scolr_pharma_reports_positive_results_from_phase_iii_pain_/</loc>
		<lastmod>2018-07-04T15:35:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/014a3macusight_names_new_vice_president_of_opera/</loc>
		<lastmod>2018-07-04T15:35:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ac48ebiocis_pharma_initiates_phase_iia_atopic_dermatitis_/</loc>
		<lastmod>2018-07-04T15:35:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3a4acbiovail_appoints_new_chief_scientific_officer_for_subsi/</loc>
		<lastmod>2018-07-04T15:35:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regulus-to-terminate-development-of-hcv-candidate-rg-101-130617-5841251/</loc>
		<lastmod>2018-07-04T15:35:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-asks-endo-to-withdraw-opana-er-over-fears-of-opioid-abuse-120617-5839957/</loc>
		<lastmod>2018-07-04T15:35:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/probiodrugs-pq912-yields-positive-results-in-phase-2-alzheimers-disease-trial-120617-5840017/</loc>
		<lastmod>2018-07-04T15:35:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9a4a0akesis_announces_new_drug_development_str/</loc>
		<lastmod>2018-07-04T15:35:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4c4bacharles_river_laboratories_international_q3_sal/</loc>
		<lastmod>2018-07-04T15:35:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c04aebavarian_nordic_reports_encouraging_safety_data_from_phase_ii_hiv_/</loc>
		<lastmod>2018-07-04T15:35:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/964a1salvat_submits_complete_response_to_fda_approvable_letter_for_cet/</loc>
		<lastmod>2018-07-04T15:35:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/264a8exelixis_and_bristolmyers_extend_research_collabor/</loc>
		<lastmod>2018-07-04T15:35:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/114b9diamyd_medical_wins_european_approval_for_phase_iii_diabetes_/</loc>
		<lastmod>2018-07-04T15:35:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2a494stereotaxis_names_ne/</loc>
		<lastmod>2018-07-04T15:35:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/diabetes-drug-ertugliflozin-meets-primary-endpoints-in-two-phase-3-studies-120617-5839998/</loc>
		<lastmod>2018-07-04T15:35:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jj-gains-all-regulatory-approvals-to-complete-30bn-actelion-acquisition-120617-5839786/</loc>
		<lastmod>2018-07-04T15:35:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/midatech-novartis-sign-global-license-agreement-for-brain-cancer-candidate-panobinostat-090617-5838490/</loc>
		<lastmod>2018-07-04T15:35:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a493insite_vision_names_new_interi/</loc>
		<lastmod>2018-07-04T15:35:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6f4b9trillium_therapeutics_names_new_board_me/</loc>
		<lastmod>2018-07-04T15:35:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c1499cornerstone_therapeutics_names_new_cha/</loc>
		<lastmod>2018-07-04T15:35:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0848eamdl_names_new_executive_chairman_an/</loc>
		<lastmod>2018-07-04T15:35:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b9496vyta_and_bioagra_settle_foreclosure_litig/</loc>
		<lastmod>2018-07-04T15:35:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/51492impulse_monitoring_and_st_vincents_medical_sign_ionm_agre/</loc>
		<lastmod>2018-07-04T15:35:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bd488agilitybio_partners_with_advinus_to_provide_digital_pathology_ser/</loc>
		<lastmod>2018-07-04T15:35:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bf481misonix_signs_new_distribution_agreement_with_eclipse_me/</loc>
		<lastmod>2018-07-04T15:35:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d648fsignature_genomic_laboratories_releases_new_microarray_for_prenatal_diag/</loc>
		<lastmod>2018-07-04T15:35:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b24b2orasure_to_launch_oraquick_advance_rapid_hiv12_antibody_test_directly_/</loc>
		<lastmod>2018-07-04T15:35:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2848dsciclones_phase_iii_hepatitis_trial_fails_end/</loc>
		<lastmod>2018-07-04T15:35:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2149fcelera_and_abbott_form_genetic_research_collabor/</loc>
		<lastmod>2018-07-04T15:35:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8548bcardo_medical_wins_fda_clearance_for_align_360_total_knee_s/</loc>
		<lastmod>2018-07-04T15:35:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/574b0prolexys_raises_20_million_in_fina/</loc>
		<lastmod>2018-07-04T15:35:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1948froche_offers_new_epigenomic_and_transcriptional_regulation_/</loc>
		<lastmod>2018-07-04T15:35:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/05496antares_announces_additional_approvals_for_needlefree_injection_d/</loc>
		<lastmod>2018-07-04T15:35:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sciclone-pharmaceuticals-to-be-acquired-by-gl-capital-led-consortium-090617-5838479/</loc>
		<lastmod>2018-07-04T15:35:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/894afsun_pharma_wins_fda_approval_for_generic_sinemet_cr_ta/</loc>
		<lastmod>2018-07-04T15:35:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/264bbpfizer_terminates_phase_iii_obesity_drug_development_pr/</loc>
		<lastmod>2018-07-04T15:35:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/valeant-to-divest-inova-pharmaceuticals-for-930m-090617-5838123/</loc>
		<lastmod>2018-07-04T15:35:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbvies-upadacitinib-meets-all-endpoints-in-phase-3-rheumatoid-arthritis-trial-080617-5837167/</loc>
		<lastmod>2018-07-04T15:35:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tevas-fremanezumab-succeeds-in-phase-3-migraine-study-080617-5837016/</loc>
		<lastmod>2018-07-04T15:35:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-synergys-snda-for-ibs-drug-trulance-080617-5836987/</loc>
		<lastmod>2018-07-04T15:35:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-to-divest-zomig-migrane-drug-rights-for-302m-070617-5836842/</loc>
		<lastmod>2018-07-04T15:35:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ad49ehospira_q3_net_inco/</loc>
		<lastmod>2018-07-04T15:35:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/584b0healthrobotics_forms_partnership_with_ahcsco/</loc>
		<lastmod>2018-07-04T15:35:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ee4abmesoblast_initiates_phase_iii_bone_marrow_transplant_/</loc>
		<lastmod>2018-07-04T15:35:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fb4acgenedata_and_genome_research_institute_form_collabor/</loc>
		<lastmod>2018-07-04T15:35:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3d48aurigen_announces_corporate_restruct/</loc>
		<lastmod>2018-07-04T15:35:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8449fb_braun_signs_infusion_pumps_contract_with_nov/</loc>
		<lastmod>2018-07-04T15:35:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bb4bcconjuchem_completes_dosing_in_phase_ii_diabetes_/</loc>
		<lastmod>2018-07-04T15:35:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0f4adaps_healthcare_relocates_headquarters_to_new/</loc>
		<lastmod>2018-07-04T15:35:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fc489assay_designs_signs_agreement_with_a/</loc>
		<lastmod>2018-07-04T15:35:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b485ois_to_launch_seven_new_pro/</loc>
		<lastmod>2018-07-04T15:35:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/51488generex_biotechnology_submits_product_dossier_to_syrian_gover/</loc>
		<lastmod>2018-07-04T15:35:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f94a8prostrakan_launches_sancuso_/</loc>
		<lastmod>2018-07-04T15:35:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c24a7accumetrics_names_new_executive_vice_president_of_operations_an/</loc>
		<lastmod>2018-07-04T15:35:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a248bhemaquest_wins_orphan_drug_designations_for_anemia/</loc>
		<lastmod>2018-07-04T15:35:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/654a6novo_nordisk_wins_fda_approval_for_new_indication_of_nordit/</loc>
		<lastmod>2018-07-04T15:35:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eleven-partners-with-astrazeneca-nci-on-therapy-for-non-muscle-invasive-bladder-cancer-070617-5835717/</loc>
		<lastmod>2018-07-04T15:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abcellera-sanofi-to-collaborate-on-antibody-discovery-for-influenza-vaccine-070617-5835703/</loc>
		<lastmod>2018-07-04T15:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2249aoncolytics_biotech_to_pursue_phase_iiiii_head_and_neck_cancer_/</loc>
		<lastmod>2018-07-04T15:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d548bmylan_wins_fda_approval_for_generic_k/</loc>
		<lastmod>2018-07-04T15:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/89484biovectra_and_therapure_partner_in_cancer_drug_develo/</loc>
		<lastmod>2018-07-04T15:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/664b8mubadala_and_labcorp_to_establish_national_reference_laboratory_in_abu_/</loc>
		<lastmod>2018-07-04T15:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aristadas-two-month-dosing-approved-by-fda-for-schizophrenia-070617-5835666/</loc>
		<lastmod>2018-07-04T15:36:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e148escri_selects_omnicomms_electronic_data_capture_sof/</loc>
		<lastmod>2018-07-04T15:36:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/carlyle-gtcr-to-buy-albany-molecular-research-for-922m-070617-5835573/</loc>
		<lastmod>2018-07-04T15:36:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/794abassureimmune_and_cenegenics_form_partne/</loc>
		<lastmod>2018-07-04T15:36:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/juno-therapeutics-reports-data-from-jcar017s-lymphoma-phase-1-trial-060617-5834380/</loc>
		<lastmod>2018-07-04T15:36:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches-perjeta-based-regimen-cuts-down-breast-cancer-recurrence-in-phase-3-trial-060617-5834266/</loc>
		<lastmod>2018-07-04T15:36:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f1482surmodics_acquires_drug_delivery_assets_from_pr_pharmaceut/</loc>
		<lastmod>2018-07-04T15:36:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b24b0arterial_remodeling_technologies_names_ne/</loc>
		<lastmod>2018-07-04T15:36:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f1490progenics_selects_hepatitis_drug_candidate_for_clinical_develo/</loc>
		<lastmod>2018-07-04T15:36:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7149fperkinelmer_names_new_vp_of_drug_discovery_and_research_rea/</loc>
		<lastmod>2018-07-04T15:36:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-ibm-to-develop-cognitive-solution-to-improve-outcomes-in-breast-cancer-060617-5834017/</loc>
		<lastmod>2018-07-04T15:36:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristol-myers-opdivo-approved-in-europe-for-urothelial-carcinoma-050617-5833127/</loc>
		<lastmod>2018-07-04T15:36:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/134b6inverness_medical_and_prognostix_sign_distribution_agre/</loc>
		<lastmod>2018-07-04T15:36:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/504a4ceregene_obtains_54_million_nih_funding_for_phase_ii_alzheimers_/</loc>
		<lastmod>2018-07-04T15:36:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b2498thermo_fisher_scientific_signs_collaboration_agreement_with_gene/</loc>
		<lastmod>2018-07-04T15:36:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c74b3oncomed_raises_93_million_in_fina/</loc>
		<lastmod>2018-07-04T15:36:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/62495bd_announces_senior_management_ch/</loc>
		<lastmod>2018-07-04T15:36:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sevion-to-acquire-eloxx-pharmaceuticals-050617-5833140/</loc>
		<lastmod>2018-07-04T15:36:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jjs-prostate-cancer-drug-zytiga-shows-significant-effect-in-phase-3-trial-050617-5833030/</loc>
		<lastmod>2018-07-04T15:36:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/florida-scientists-make-breakthrough-on-ebola-virus-020617-5832065/</loc>
		<lastmod>2018-07-04T15:36:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b94a6vaccitest_signs_new_licensing_agreement_with_magnabiosci/</loc>
		<lastmod>2018-07-04T15:36:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8e49bmedarex_obtains_milestone_payment_from_centoco/</loc>
		<lastmod>2018-07-04T15:36:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e84b2akesis_pharmaceuticals_names_ne/</loc>
		<lastmod>2018-07-04T15:36:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/61486replidyne_and_cardiovascular_systems_sign_merger_agre/</loc>
		<lastmod>2018-07-04T15:36:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e24bedebiopharm_submits_response_to_fda_for_haemorrhage/</loc>
		<lastmod>2018-07-04T15:36:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/obi-pharma-acquires-akr1c3-inhibiting-cancer-prodrug-from-threshold-020617-5832045/</loc>
		<lastmod>2018-07-04T15:36:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/viiv-healthcare-seeks-ema-fda-approvals-for-two-drug-regimen-to-treat-hiv-1-infection-020617-5831762/</loc>
		<lastmod>2018-07-04T15:36:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tevas-phase-3-study-of-migraine-drug-fremanezumab-yields-positive-results-010617-5830682/</loc>
		<lastmod>2018-07-04T15:36:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1e484mediware_licenses_biologicare_to_hospital_for_special_su/</loc>
		<lastmod>2018-07-04T15:36:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2048apediatrix_acquires_neonatal_practice_in_loui/</loc>
		<lastmod>2018-07-04T15:36:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/84498genzyme_and_osiris_collaborate_to_develop_adult_stem_cell_pro/</loc>
		<lastmod>2018-07-04T15:36:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/624a6source_bioscience_expands_distribution_network_in_east/</loc>
		<lastmod>2018-07-04T15:36:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ae4b5sinclair_pharma_names_new_vice_president_of_business_develo/</loc>
		<lastmod>2018-07-04T15:36:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roquette-to-acquire-brazilian-pharmaceutical-tablet-maker-itacel-010617-5830668/</loc>
		<lastmod>2018-07-04T15:36:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lillys-cyramza-succeeds-in-phase-3-urothelial-cancer-trial-010617-5830619/</loc>
		<lastmod>2018-07-04T15:36:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immunogen-and-sanofi-modify-license-agreement-to-include-more-compounds-310517-5829376/</loc>
		<lastmod>2018-07-04T15:36:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9a490teva_reports_positive_data_from_study_of_parkinsons/</loc>
		<lastmod>2018-07-04T15:36:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6f4a5astrazenecas_executive_director_to_r/</loc>
		<lastmod>2018-07-04T15:36:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d74b0nicox_reports_positive_blood_pressure_data_for_arthritis/</loc>
		<lastmod>2018-07-04T15:36:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/be4b4roche_nimblegen_introduces_new_version_of_genome_sequencing/</loc>
		<lastmod>2018-07-04T15:36:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6049fgalapagos_sells_san_diego_chemistry_facility_to_chemven/</loc>
		<lastmod>2018-07-04T15:36:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizers-trumenba-vaccine-for-meningococcal-group-b-disease-approved-in-europe-310517-5829363/</loc>
		<lastmod>2018-07-04T15:36:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eisai-and-charles-river-extend-integrated-drug-discovery-collaboration-300517-5828036/</loc>
		<lastmod>2018-07-04T15:36:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lysogene-completes-enrollment-for-samos-trial-300517-5828032/</loc>
		<lastmod>2018-07-04T15:36:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2e4a6tomotherapy_acquires_chengdu_twin_peak_accelerator_technol/</loc>
		<lastmod>2018-07-04T15:36:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8d495mpathy_medical_launches_restore/</loc>
		<lastmod>2018-07-04T15:36:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d14b9syneron_medical_acquires_in/</loc>
		<lastmod>2018-07-04T15:36:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/484a0osmetech_launches_new_genetic/</loc>
		<lastmod>2018-07-04T15:36:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/834aapegasus_pharmaceuticals_completes_rd_of_new_heartvue_monitoring_s/</loc>
		<lastmod>2018-07-04T15:36:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/motor-neurone-disease-drug-shows-significant-effect-in-uos-researchers-study-300517-5827948/</loc>
		<lastmod>2018-07-04T15:36:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sunovion-receives-complete-response-letter-for-sun-101eflow-from-fda-290517-5826976/</loc>
		<lastmod>2018-07-04T15:36:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-recalls-one-lot-of-brilinta-90mg-bottles-in-us-290517-5826965/</loc>
		<lastmod>2018-07-04T15:36:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8c4a7cornerstone_completes_merger_with_critical_therapeut/</loc>
		<lastmod>2018-07-04T15:36:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3d4abaffymax_completes_enrollment_in_second_phase_iii_anemia_/</loc>
		<lastmod>2018-07-04T15:36:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fd4b1medimmune_initiates_phase_iiia_rsv_vaccine_/</loc>
		<lastmod>2018-07-04T15:36:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8b4a2tripos_international_acquires_phar/</loc>
		<lastmod>2018-07-04T15:36:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a14b3generic_drugs_lower_us_medicare_/</loc>
		<lastmod>2018-07-04T15:36:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uks-nice-recommends-novartiss-afinitor-for-treating-neuroendocrine-tumours-290517-5826835/</loc>
		<lastmod>2018-07-04T15:36:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-tejin-sign-license-agreement-for-tau-targeting-antibody-260517-5825579/</loc>
		<lastmod>2018-07-04T15:36:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/harpoon-therapeutics-raises-45m-in-new-funding-round-260517-5825571/</loc>
		<lastmod>2018-07-04T15:36:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/744a6actavis_establishes_new_rd_labs_in_fl/</loc>
		<lastmod>2018-07-04T15:36:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/22492pronova_biopharma_names_ne/</loc>
		<lastmod>2018-07-04T15:36:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-panel-recommends-pfizers-epoetin-alfa-biosimilar-to-treat-anemia-260517-5825296/</loc>
		<lastmod>2018-07-04T15:36:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/neurocrines-tourette-syndrome-drug-ingrezza-fails-in-phase-2-trial-250517-5824266/</loc>
		<lastmod>2018-07-04T15:36:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/804a3canopus_biopharma_reports_positive_results_from_cancer_vaccine_/</loc>
		<lastmod>2018-07-04T15:36:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f9489licor_biosciences_and_mandel_scientific_sign_distribution_agre/</loc>
		<lastmod>2018-07-04T15:36:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a14b8covidien_and_petnet_solutions_sign_comarketing_agre/</loc>
		<lastmod>2018-07-04T15:36:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/debiopharm-acquires-immunogens-tumour-drug-imgn529debio-1562-250517-5824253/</loc>
		<lastmod>2018-07-04T15:36:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f349fcelsci_expands_licensing_agreement_with_orient_europ/</loc>
		<lastmod>2018-07-04T15:36:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cd49bfluxion_signs_distribution_agreement_with_la/</loc>
		<lastmod>2018-07-04T15:36:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f348empex_pharmaceuticals_initiates_phase_ii_copd_/</loc>
		<lastmod>2018-07-04T15:36:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/444aahalozyme_therapeutics_initiates_phase_ii_diabetes_/</loc>
		<lastmod>2018-07-04T15:36:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/954a6portola_initiates_enrollment_for_phase_ii_atrial_fibrillation_/</loc>
		<lastmod>2018-07-04T15:36:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inovios-hiv-vaccine-combination-pennvax-gp-succeeds-in-early-stage-clinical-trial-250517-5824211/</loc>
		<lastmod>2018-07-04T15:36:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inovios-hiv-vaccine-combination-pennvax-gp-succeeds-in-early-stage-trial-250517-5824210/</loc>
		<lastmod>2018-07-04T15:36:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mercks-keytruda-approved-by-fda-to-treat-cancer-with-genetic-defects-240517-5822920/</loc>
		<lastmod>2018-07-04T15:36:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9e4b6medarex_reports_positive_topline_results_from_phase_ii_diarrhea_/</loc>
		<lastmod>2018-07-04T15:36:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f348baurora_imaging_wins_fda_clearance_for_spectroscopy_techn/</loc>
		<lastmod>2018-07-04T15:36:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1a4adaryx_completes_enrollment_in_phase_iiiii_anticoagulation_comparison_/</loc>
		<lastmod>2018-07-04T15:36:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/17491new_medical_center_may_open_in_/</loc>
		<lastmod>2018-07-04T15:36:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uks-cma-accuses-merck-of-breaching-competition-law-240517-5822905/</loc>
		<lastmod>2018-07-04T15:36:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentechs-actemra-approved-by-fda-for-giant-cell-arteritis-treatment-230517-5821548/</loc>
		<lastmod>2018-07-04T15:36:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nektar-takeda-collaborate-for-combination-cancer-therapy-230517-5821533/</loc>
		<lastmod>2018-07-04T15:36:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/recordati-to-buy-astrazenecas-european-betablocker-treatments-for-300m-230517-5821383/</loc>
		<lastmod>2018-07-04T15:36:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/proteorex-corbin-partner-on-novel-ubiquitin-specific-protease-inhibitors-220517-5820376/</loc>
		<lastmod>2018-07-04T15:36:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a54b6curagen_reports_encouraging_preliminary_data_from_phase_ii_melanoma_/</loc>
		<lastmod>2018-07-04T15:36:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cd49cbionovo_to_advance_breast_cancer_drug_to_phase_ii_st/</loc>
		<lastmod>2018-07-04T15:36:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/iterum-raises-65m-in-new-financing-round-220517-5820362/</loc>
		<lastmod>2018-07-04T15:36:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0348aneostem_to_acquire_hong_kong_co/</loc>
		<lastmod>2018-07-04T15:36:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/274a4atcor_medical_to_introduce_new_portable_sphygmocor_syst/</loc>
		<lastmod>2018-07-04T15:36:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d9485virtual_radiologic_signs_teleradiology_agreement_wit/</loc>
		<lastmod>2018-07-04T15:36:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chmp-recommends-approval-for-lung-cancer-drug-zykadias-expanded-use-220517-5820219/</loc>
		<lastmod>2018-07-04T15:36:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen-submits-bla-of-migraine-drug-erenumab-to-fda-190517-5818920/</loc>
		<lastmod>2018-07-04T15:36:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-imposes-clinical-hold-on-concerts-hair-loss-drug-alopecia-areata-190517-5818906/</loc>
		<lastmod>2018-07-04T15:36:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0b4abzymogenetics_reports_positive_interim_results_from_phase_ib_hepatitis_/</loc>
		<lastmod>2018-07-04T15:36:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shires-swelling-disorder-drug-meets-primary-and-secondary-endpoints-in-phase-3-study-190517-5818740/</loc>
		<lastmod>2018-07-04T15:36:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/de499genentech_files_sbla_for_avastin_in_brain_c/</loc>
		<lastmod>2018-07-04T15:36:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6e491misonix_signs_new_distribution_agreement_with_imaging_equi/</loc>
		<lastmod>2018-07-04T15:36:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c4496cardiac_science_names_new_executive_vice_president_an/</loc>
		<lastmod>2018-07-04T15:36:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec492sanofiaventis_q3_net_inco/</loc>
		<lastmod>2018-07-04T15:36:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immunogens-ovarian-cancer-drug-yields-positive-results-in-early-stage-trials-180517-5817536/</loc>
		<lastmod>2018-07-04T15:36:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aduro-biotech-evaluate-crs-207-and-keytruda-combination-for-mesothelioma-180517-5817516/</loc>
		<lastmod>2018-07-04T15:36:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cb4a3avigen_announces_corporate_restruct/</loc>
		<lastmod>2018-07-04T15:36:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bayers-copanlisib-gets-priority-review-from-fda-for-follicular-lymphoma-180517-5817442/</loc>
		<lastmod>2018-07-04T15:36:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogen-acquires-stroke-drug-cirara-from-remedy-for-120m-170517-5816121/</loc>
		<lastmod>2018-07-04T15:36:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec-launches-investigation-into-aspens-pricing-patterns-for-cancer-drugs-170517-5816109/</loc>
		<lastmod>2018-07-04T15:36:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a549dtrianim_signs_specialty_distribution_agreement_with_pr/</loc>
		<lastmod>2018-07-04T15:36:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6f484critical_outcome_technologies_names_ne/</loc>
		<lastmod>2018-07-04T15:36:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c4489source_mdx_announces_research_partnership_with_brigham_and_womens_hos/</loc>
		<lastmod>2018-07-04T15:36:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fa49abiomarin_initiates_clinical_assessment_program_for_morquio_a_syn/</loc>
		<lastmod>2018-07-04T15:36:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/summit-completes-patient-enrolment-in-phase-2-trial-of-dmd-drug-ezutromid-160517-5814894/</loc>
		<lastmod>2018-07-04T15:36:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ibm-researchers-find-new-method-to-trigger-bodys-immune-response-160517-5814877/</loc>
		<lastmod>2018-07-04T15:36:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/thermo-fisher-scientific-to-buy-patheon-for-72bn-160517-5814627/</loc>
		<lastmod>2018-07-04T15:36:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9f4b0misonix_signs_interim_distribution_agreement_with_lithom/</loc>
		<lastmod>2018-07-04T15:36:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c549emannatech_launches_operations_in_sing/</loc>
		<lastmod>2018-07-04T15:36:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ac49fevestra_establishes_european_subsidiary_in_ge/</loc>
		<lastmod>2018-07-04T15:36:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2848fneostem_to_acquire_controlling_stake_in_china_biopharmaceuticals_hol/</loc>
		<lastmod>2018-07-04T15:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/704bbakornstrides_wins_fda_approval_for_pamidronate_disodium_inje/</loc>
		<lastmod>2018-07-04T15:37:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/314b1medgenics_reports_promising_preliminary_data_from_phase_iii_renal_anemia_/</loc>
		<lastmod>2018-07-04T15:37:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ardelyxs-ibs-c-drug-tenapanor-yields-positive-results-in-first-phase-3-trial-150517-5813662/</loc>
		<lastmod>2018-07-04T15:37:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lillys-migraine-drug-galcanezumab-succeeds-in-phase-3-studies-150517-5813635/</loc>
		<lastmod>2018-07-04T15:37:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-lung-cancer-drug-imfinzi-improves-survival-in-phase-3-trial-150517-5813608/</loc>
		<lastmod>2018-07-04T15:37:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/82490globeimmune_reports_promising_results_from_phase_ii_hepatitis_/</loc>
		<lastmod>2018-07-04T15:37:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2548dscheringplough_reports_positive_interim_results_from_phase_ii_hepatitis_/</loc>
		<lastmod>2018-07-04T15:37:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b6496anadys_reports_encouraging_results_from_phase_i_hepatitis_/</loc>
		<lastmod>2018-07-04T15:37:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a24b0celldex_reports_encouraging_data_from_phase_i_cancer_/</loc>
		<lastmod>2018-07-04T15:37:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/reneuron-secures-grant-for-uk-cell-therapy-manufacturing-120517-5812437/</loc>
		<lastmod>2018-07-04T15:37:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/clinigen-tesaro-launch-program-for-niraparib-for-recurrent-ovarian-cancer-120517-5812425/</loc>
		<lastmod>2018-07-04T15:37:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-turns-down-hikma-vecturas-application-on-generic-asthma-drug-120517-5812033/</loc>
		<lastmod>2018-07-04T15:37:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/734b0pacira_pharmaceuticals_leverages_salarycoms_talentma/</loc>
		<lastmod>2018-07-04T15:37:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/99486daiichi_sankyo_acquires_merck_seronos_cardiometabolism_sales_force_in_t/</loc>
		<lastmod>2018-07-04T15:37:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1f4a0alphatec_spine_names_new_vp_and_general_manager_of_e/</loc>
		<lastmod>2018-07-04T15:37:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/014b0mobile_diagnostic_centers_names_ne/</loc>
		<lastmod>2018-07-04T15:37:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c248bbristolmyers_squibb_to_award_14_million_for_hepatitis_awareness_in/</loc>
		<lastmod>2018-07-04T15:37:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches-advanced-bladder-cancer-drug-tecentriq-fails-in-phase-3-trial-110517-5811062/</loc>
		<lastmod>2018-07-04T15:37:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mercks-keytruda-regimen-gets-fda-approval-for-metastatic-nsclc-treatment-110517-5811043/</loc>
		<lastmod>2018-07-04T15:37:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/inc-research-and-inventiv-to-merge-in-46bn-contract-medical-research-deal-110517-5810903/</loc>
		<lastmod>2018-07-04T15:37:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f1484vnus_medical_names_new_chief_medical_of/</loc>
		<lastmod>2018-07-04T15:37:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b44a2lifeclinic_international_names_new_chief_medical_of/</loc>
		<lastmod>2018-07-04T15:37:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/584b6savient_files_bla_for_gout/</loc>
		<lastmod>2018-07-04T15:37:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/384a5salix_wins_fda_approval_for_ulcer/</loc>
		<lastmod>2018-07-04T15:37:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/array-merck-to-evaluate-binimetinib-and-keytruda-combination-for-colorectal-cancer-100517-5809465/</loc>
		<lastmod>2018-07-04T15:37:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-initiates-phase-3b-study-of-lixiana-100517-5809488/</loc>
		<lastmod>2018-07-04T15:37:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xylocors-cardiovascular-gene-therapy-gets-fda-fast-track-designation-090517-5808272/</loc>
		<lastmod>2018-07-04T15:37:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/db489national_jewish_health_signs_copromotion_agreement_with_p/</loc>
		<lastmod>2018-07-04T15:37:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/174b9sartorius_stedim_biotech_to_acquire_wave_bi/</loc>
		<lastmod>2018-07-04T15:37:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/314aaanika_signs_new_distribution_agreements_for_injectable_dermal_f/</loc>
		<lastmod>2018-07-04T15:37:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/12487cyanotech_names_ne/</loc>
		<lastmod>2018-07-04T15:37:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f4491misonix_signs_new_distribution_agreement_with_stme/</loc>
		<lastmod>2018-07-04T15:37:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7149fresponse_biomedical_raises_51_million_in_financin/</loc>
		<lastmod>2018-07-04T15:37:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/myovants-hormonal-therapy-relugolix-succeeds-in-phase-2-trial-090517-5808286/</loc>
		<lastmod>2018-07-04T15:37:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-sandoz-durect-sign-293m-deal-for-pain-killer-posimir-090517-5808108/</loc>
		<lastmod>2018-07-04T15:37:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/asthma-drug-relvar-ellipta-succeeds-in-phase-3-trial-080517-5806949/</loc>
		<lastmod>2018-07-04T15:37:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/244b1pfizer_wins_fda_approval_for_bladder/</loc>
		<lastmod>2018-07-04T15:37:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ee4b5provectus_adds_fifth_center_to_phase_ii_melanoma_/</loc>
		<lastmod>2018-07-04T15:37:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ff4bbpacgen_names_new_interim_president_an/</loc>
		<lastmod>2018-07-04T15:37:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3c49ecephalon_wins_fda_approval_for_lymphoma/</loc>
		<lastmod>2018-07-04T15:37:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/laquinimod-fails-to-meet-primary-endpoint-in-multiple-sclerosis-trial-080517-5806943/</loc>
		<lastmod>2018-07-04T15:37:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/jj-ordered-to-pay-110m-to-ovarian-cancer-victim-in-talcum-powder-lawsuit-080517-5806925/</loc>
		<lastmod>2018-07-04T15:37:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ce491akorn_wins_fda_approval_for_adenosine_inje/</loc>
		<lastmod>2018-07-04T15:37:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/vivet-raises-375m-to-advance-gene-therapies-for-metabolic-diseases-050517-5805992/</loc>
		<lastmod>2018-07-04T15:37:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1b481bristolmyers_squibb_presents_positive_data_from_hepatitis_b_/</loc>
		<lastmod>2018-07-04T15:37:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/08497janssen_presents_positive_results_from_schizoaffective_disorder_/</loc>
		<lastmod>2018-07-04T15:37:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9149egilead_sciences_presents_positive_data_from_phase_iii_hbv_st/</loc>
		<lastmod>2018-07-04T15:37:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/poxels-diabetes-drug-imeglimin-succeeds-in-phase-2b-study-in-japan-050517-5805963/</loc>
		<lastmod>2018-07-04T15:37:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-exercises-option-to-develop-conatus-emricasan-to-treat-nash-050517-5805546/</loc>
		<lastmod>2018-07-04T15:37:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-snda-of-pfizers-arthritis-drug-xeljanz-040517-5804634/</loc>
		<lastmod>2018-07-04T15:37:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4b48dbiohit_introduces_new_cancer_diagnostic_/</loc>
		<lastmod>2018-07-04T15:37:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8a4beavineuro_completes_preclinical_studies_of_alzheimers/</loc>
		<lastmod>2018-07-04T15:37:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f54b7tibotec_presents_positive_interim_findings_from_phase_iia_hepatitis_/</loc>
		<lastmod>2018-07-04T15:37:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6d4a2is_pharma_introduces_isoplex_/</loc>
		<lastmod>2018-07-04T15:37:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ab485neoprobe_wins_emea_positive_response_for_rigsc/</loc>
		<lastmod>2018-07-04T15:37:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d04a5cti_closes_data_set_for_endpoint_analysis_in_phase_iii_lymphoma_/</loc>
		<lastmod>2018-07-04T15:37:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/384a3oncolytics_reports_positive_results_from_phase_iii_cancer_st/</loc>
		<lastmod>2018-07-04T15:37:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sosei-makes-strategic-investment-in-mina-therapeutics-040517-5804611/</loc>
		<lastmod>2018-07-04T15:37:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-pieris-collaborate-on-novel-respiratory-treatments-040517-5804449/</loc>
		<lastmod>2018-07-04T15:37:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ae4b7spectrum_pharmaceuticals_files_snda_for_fusilev_in_colorectal_c/</loc>
		<lastmod>2018-07-04T15:37:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0749dpolyphor_signs_licensing_agreement_with_all/</loc>
		<lastmod>2018-07-04T15:37:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/celyad-grants-non-exclusive-license-for-allogeneic-tcr-deficient-car-t-cells-patents-to-novartis-030517-5803243/</loc>
		<lastmod>2018-07-04T15:37:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c04b2sigmaaldrich_launches_new_methylated_dna_quantification_techn/</loc>
		<lastmod>2018-07-04T15:37:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/90494imclone_and_bristolmyers_squibbs_cancer_drug_sbla_wins_fda_priority_r/</loc>
		<lastmod>2018-07-04T15:37:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f24a6stemcells_reports_promising_results_from_human_neural_stem_cells_/</loc>
		<lastmod>2018-07-04T15:37:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-bladder-cancer-drug-imfinzi-gets-accelerated-approval-from-fda-030517-5803270/</loc>
		<lastmod>2018-07-04T15:37:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire-and-parion-to-advance-p-321-for-ophthalmic-indications-020517-5801923/</loc>
		<lastmod>2018-07-04T15:37:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sunesis-to-withdraw-vosaroxin-treatment-for-aml-in-europe-020517-5801906/</loc>
		<lastmod>2018-07-04T15:37:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b049aresponse_biomedical_launches_ramp_technology_in_3ms_flu/</loc>
		<lastmod>2018-07-04T15:37:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/664a3aastrom_achieves_milestone_in_phase_iib_critical_limb_ischemia_/</loc>
		<lastmod>2018-07-04T15:37:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/70484pioneer_surgicals_nubac_device_wins_approval_for_ide_/</loc>
		<lastmod>2018-07-04T15:37:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aeterna-zentaris-cancer-drug-zoptrex-fails-to-meet-primary-endpoint-in-phase-iii-trial-020517-5801469/</loc>
		<lastmod>2018-07-04T15:37:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d04aasurmodics_to_provide_hydrophilic_coating_to_elixir_medicals_stent_sy/</loc>
		<lastmod>2018-07-04T15:37:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e9482ats_medical_wins_fda_approval_for_ats_3f_aortic_bioprost/</loc>
		<lastmod>2018-07-04T15:37:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bristol-myers-squibb-not-to-acquire-f-star-alpha-010517-5800791/</loc>
		<lastmod>2018-07-04T15:37:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takedas-lung-cancer-drug-alunbrig-secures-fda-accelerated-approval-010517-5800775/</loc>
		<lastmod>2018-07-04T15:37:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-rydapt-regimen-approved-by-fda-for-acute-myeloid-leukemia-010517-5800601/</loc>
		<lastmod>2018-07-04T15:37:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-harrington-to-advance-development-of-rare-disease-therapeutics-280417-5799583/</loc>
		<lastmod>2018-07-04T15:37:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizers-lung-cancer-drug-lorlatinib-gets-fda-breakthrough-therapy-designation-280417-5799553/</loc>
		<lastmod>2018-07-04T15:37:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/064a0hospiras_new_indication_for_precedex_receives_fda_app/</loc>
		<lastmod>2018-07-04T15:37:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bc482mabcure_establishes_new_belgian_subsi/</loc>
		<lastmod>2018-07-04T15:37:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/db48fge_healthcare_acquires_vital_/</loc>
		<lastmod>2018-07-04T15:37:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e74b9china_sky_one_medical_wins_production_approval_for_two_new_/</loc>
		<lastmod>2018-07-04T15:37:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3e496aldagen_obtains_orphan_drug_designation_for_blood_transplant/</loc>
		<lastmod>2018-07-04T15:37:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazeneca-returns-asthma-experimental-drug-rights-to-synairgen-280417-5799429/</loc>
		<lastmod>2018-07-04T15:37:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shire-wins-ec-conditional-approval-for-natpar-to-treat-hypoparathyroidism-270417-5798535/</loc>
		<lastmod>2018-07-04T15:37:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/teva-launches-generic-vytorin-in-us-270417-5798304/</loc>
		<lastmod>2018-07-04T15:37:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/da4aebayhill_therapeutics_and_jdrf_partner_in_diabetes_drug_develo/</loc>
		<lastmod>2018-07-04T15:37:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ef498innexus_biotechnology_expands_antibody_patent_portfolio_in_e/</loc>
		<lastmod>2018-07-04T15:37:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b44acgenaeras_partner_medimmune_reports_interim_data_from_phase_iia_asthma_/</loc>
		<lastmod>2018-07-04T15:37:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c14b4daiichi_sankyo_to_dissolve_subsidiaries_with_sanofiav/</loc>
		<lastmod>2018-07-04T15:37:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b74bfdor_biopharma_expands_collaboration_with_burnsadler_pharmaceutic/</loc>
		<lastmod>2018-07-04T15:37:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/arsanis-secures-455m-in-new-funding-round-270417-5798294/</loc>
		<lastmod>2018-07-04T15:37:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/akebia-otsuka-sign-865m-expanded-collaboration-and-license-deal-for-vadadustat-260417-5796746/</loc>
		<lastmod>2018-07-04T15:37:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uniqures-gene-therapy-for-severe-hemophilia-b-gets-prime-designation-in-europe-260417-5796800/</loc>
		<lastmod>2018-07-04T15:37:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/214a4oridion_systems_signs_purchase_agreement_with_kaiser_foundation_health/</loc>
		<lastmod>2018-07-04T15:37:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b74b5interna_and_vu_university_medical_center_sign_research_agre/</loc>
		<lastmod>2018-07-04T15:37:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0f489karo_bio_completes_phase_ii_dyslipidemia_tr/</loc>
		<lastmod>2018-07-04T15:37:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a4482evotec_receives_two_milestone_payments_from_boehringer_inge/</loc>
		<lastmod>2018-07-04T15:37:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/science-37-raises-29m-site-less-clinical-trials-260417-5796784/</loc>
		<lastmod>2018-07-04T15:37:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d74a3akela_pharma_achieves_second_milestone_in_phase_iii_cancer_pain_/</loc>
		<lastmod>2018-07-04T15:37:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ec-approves-astrazenecas-tagrisso-to-treat-mutation-positive-nsclc-260417-5796478/</loc>
		<lastmod>2018-07-04T15:37:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizers-zavicefta-shown-to-match-standard-of-care-hap-treatment-in-phase-3-study-250417-5795393/</loc>
		<lastmod>2018-07-04T15:37:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/europes-chmp-recommends-kevzara-for-rheumatoid-arthritis-250417-5795368/</loc>
		<lastmod>2018-07-04T15:37:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d54b5xenomics_signs_licensing_agreement_with_seq/</loc>
		<lastmod>2018-07-04T15:37:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e44a5anadys_initiates_dosing_in_phase_i_hepatitis_c_/</loc>
		<lastmod>2018-07-04T15:37:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f54aaaccumetrics_names_ne/</loc>
		<lastmod>2018-07-04T15:37:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ad4b6roche_wins_fda_approval_for_hepatitis_c_viral_load/</loc>
		<lastmod>2018-07-04T15:37:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fresenius-kabi-to-buy-generic-drugmaker-akorn-for-43bn-250417-5795166/</loc>
		<lastmod>2018-07-04T15:37:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uniqure-to-withdraw-glybera-gene-therapy-in-europe-240417-5794018/</loc>
		<lastmod>2018-07-04T15:37:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/af495bioheart_and_monebo_sign_distribution_and_licensing_agre/</loc>
		<lastmod>2018-07-04T15:37:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ngm-bios-ngm282-succeeds-in-nonalcoholic-steatohepatitis-phase-2-trial-240417-5794070/</loc>
		<lastmod>2018-07-04T15:37:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/chmp-recommends-sandoz-biosimilars-rituximab-and-etanercept-for-approval-240417-5793964/</loc>
		<lastmod>2018-07-04T15:37:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-rejects-vernalis-nda-for-cough-cold-treatment-ccp-07-240417-5793963/</loc>
		<lastmod>2018-07-04T15:37:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ba4b3nabi_reports_positive_results_from_phase_ii_nicvax_immunogenicity_/</loc>
		<lastmod>2018-07-04T15:37:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6f491gsk_reports_encouraging_results_from_bone_density_study_in_copd_patie/</loc>
		<lastmod>2018-07-04T15:37:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/214adshire_reports_encouraging_results_from_adhd_/</loc>
		<lastmod>2018-07-04T15:37:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ab4b7northfield_laboratories_files_bla_for_pol/</loc>
		<lastmod>2018-07-04T15:37:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ff484bard_wins_fda_approval_for_flair_endovascular_stent_/</loc>
		<lastmod>2018-07-04T15:37:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/abbvies-gp-regimen-cures-most-patients-in-phase-3-hepatitis-c-trial-210417-5792870/</loc>
		<lastmod>2018-07-04T15:37:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/h3-biomedicine-foundation-medicine-extend-collaboration-on-precision-cancer-therapies-210417-5792946/</loc>
		<lastmod>2018-07-04T15:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pint-gets-rights-of-ceplene-in-latin-america-from-immune-210417-5792888/</loc>
		<lastmod>2018-07-04T15:38:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bb4a4occulogix_submits_premarket_notification_for_tearlab_osmolarity_s/</loc>
		<lastmod>2018-07-04T15:38:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2948fwelichem_reports_positive_results_from_phase_iia_atopic_dermatitis_tr/</loc>
		<lastmod>2018-07-04T15:38:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sawai-to-buy-upshersmiths-generic-pharmaceuticals-business-for-105bn-210417-5792718/</loc>
		<lastmod>2018-07-04T15:38:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-buys-rights-for-parvus-navacim-technology-for-type-1-diabetes-200417-5791632/</loc>
		<lastmod>2018-07-04T15:38:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/burosumab-yields-positive-results-in-phase-3-x-linked-hypophosphatemia-trial-200417-5791713/</loc>
		<lastmod>2018-07-04T15:38:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f94afalvine_reports_positive_results_from_phase_i_celiac_disease_/</loc>
		<lastmod>2018-07-04T15:38:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/444b1vermillion_extends_research_collaboration_with_quest_diagno/</loc>
		<lastmod>2018-07-04T15:38:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f2487biovest_signs_distribution_agreement_with/</loc>
		<lastmod>2018-07-04T15:38:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/alpine-immune-to-merge-with-nivalis-therapeutics-200417-5791701/</loc>
		<lastmod>2018-07-04T15:38:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/124a6telik_reports_topline_results_from_phase_iii_ovarian_cancer_/</loc>
		<lastmod>2018-07-04T15:38:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/024b8theratechnologies_and_emd_serono_sign_collaboration_and_licensing_agre/</loc>
		<lastmod>2018-07-04T15:38:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/relypsas-veltassa-shows-consistent-efficacy-in-phase-4-trial-to-treat-hyperkalemia-200417-5791573/</loc>
		<lastmod>2018-07-04T15:38:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mateons-phase-23-trial-in-platinum-resistant-ovarian-cancer-yields-positive-results-190417-5790388/</loc>
		<lastmod>2018-07-04T15:38:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/44487ophthotech_initiates_patient_enrollment_in_phase_i_amd_/</loc>
		<lastmod>2018-07-04T15:38:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3a48fzila_wins_marketing_authorization_for_oral_cancer_diagnosti/</loc>
		<lastmod>2018-07-04T15:38:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2f49emethylgene_reacquires_rights_to_cancer_drug_from_ce/</loc>
		<lastmod>2018-07-04T15:38:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/hitgen-pfizer-to-build-and-screen-novel-dna-encoded-libraries-190417-5790376/</loc>
		<lastmod>2018-07-04T15:38:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-gets-fda-breakthrough-therapy-status-for-ctl019-to-treat-rr-dlbcl-190714-5790125/</loc>
		<lastmod>2018-07-04T15:38:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oncomeds-small-cell-lung-cancer-drug-tarextumab-fails-in-phase-2-trial-180417-5789001/</loc>
		<lastmod>2018-07-04T15:38:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/454b1generex_biotechnology_wins_new_drug_delivery_p/</loc>
		<lastmod>2018-07-04T15:38:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/394abdigestive_care_completes_nda_submission_for_pancreatic/</loc>
		<lastmod>2018-07-04T15:38:12+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/144baspectracell_expands_operations_in_new_fac/</loc>
		<lastmod>2018-07-04T15:38:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8a4b1infinity_pharmaceuticals_expands_phase_ii_lung_cancer_/</loc>
		<lastmod>2018-07-04T15:38:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/994ablpath_and_merck_serono_form_alliance_for_cancer_drug_develo/</loc>
		<lastmod>2018-07-04T15:38:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentechs-ranibizumab-injection-approved-by-fda-for-diabetic-retinopathy-180417-5789089/</loc>
		<lastmod>2018-07-04T15:38:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-to-review-pumas-neratinib-for-extended-breast-cancer-indication-180417-5789077/</loc>
		<lastmod>2018-07-04T15:38:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4b4b5perrigo_wins_fda_tentative_approval_for_generic_advil_pm_ta/</loc>
		<lastmod>2018-07-04T15:38:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e54b5misonix_signs_new_distribution_agreement_with_ultra_ultra/</loc>
		<lastmod>2018-07-04T15:38:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches-emicizumabs-trial-shows-significant-effect-to-treat-children-with-haemophilia-a-180417-5788916/</loc>
		<lastmod>2018-07-04T15:38:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5d481novartis_wins_swiss_approval_for_new_blood_pressure/</loc>
		<lastmod>2018-07-04T15:38:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cf492morria_reports_encouraging_results_from_phase_ii_allergic_rhinitis_/</loc>
		<lastmod>2018-07-04T15:38:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9249aastrazeneca_and_md_anderson_renew_cancer_research_collabor/</loc>
		<lastmod>2018-07-04T15:38:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/374b2allergan_and_spectrum_pharmaceuticals_partner_in_cancer_drug_develo/</loc>
		<lastmod>2018-07-04T15:38:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/884a8osteotech_wins_fda_clearance_for_grafting_mat/</loc>
		<lastmod>2018-07-04T15:38:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/icon-bioscience-submits-nda-for-anti-inflammatory-drug-dexycu-to-fda-170417-5787970/</loc>
		<lastmod>2018-07-04T15:38:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lyndra-secures-23m-in-series-a-funding-to-develop-therapeutic-oral-delivery-platform-170417-5787979/</loc>
		<lastmod>2018-07-04T15:38:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-rejects-eli-lillys-nda-for-rheumatoid-arthritis-drug-baricitinib-170417-5787879/</loc>
		<lastmod>2018-07-04T15:38:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a44besanofiaventis_wins_fda_approval_for_diabetes/</loc>
		<lastmod>2018-07-04T15:38:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/584a7spartan_bioscience_and_nordiag_sign_new_collaboration_agre/</loc>
		<lastmod>2018-07-04T15:38:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/964a0china_pharma_to_initiate_clinical_studies_for_new_antibiotic_combin/</loc>
		<lastmod>2018-07-04T15:38:20+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/130417biocryst-to-explore-bcx7353-use-in-acute-hae-attacks-5786829/</loc>
		<lastmod>2018-07-04T15:38:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/active-biotechs-tasquinimod-gets-orphan-drug-designation-for-multiple-myeloma-treatment-130417-5786809/</loc>
		<lastmod>2018-07-04T15:38:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novans-sb208-trial-shows-significant-effect-to-treat-superficial-cutaneous-fungal-infections-130417-5786469/</loc>
		<lastmod>2018-07-04T15:38:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/624a9dune_medical_launches_clinical_study_of_marginprobe_detection_s/</loc>
		<lastmod>2018-07-04T15:38:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/264abamgen_and_wyeth_announce_positive_data_from_arthritis_drug_/</loc>
		<lastmod>2018-07-04T15:38:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bb4a6boston_scientifics_spinal_cord_stimulation_therapy_wins_nice_recommend/</loc>
		<lastmod>2018-07-04T15:38:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/02497ivera_medical_wins_fda_clearance_for_decontamination_d/</loc>
		<lastmod>2018-07-04T15:38:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a64baagile_therapeutics_wins_patent_for_transdermal_technology_in_contrace/</loc>
		<lastmod>2018-07-04T15:38:24+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/oncomeds-demcizumab-fails-to-meet-primary-endpoint-in-pancreatic-cancer-trial-120417-5785565/</loc>
		<lastmod>2018-07-04T15:38:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/puretech-health-launches-new-immuno-oncology-programme-120417-5785547/</loc>
		<lastmod>2018-07-04T15:38:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/single-dose-of-live-attenuated-zika-vaccine-shown-to-protect-mice-120417-5785445/</loc>
		<lastmod>2018-07-04T15:38:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/564afimclone_launches_new_cancer_drug_in_c/</loc>
		<lastmod>2018-07-04T15:38:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/78495clrs_technology_wins_fda_clearance_for_claro_acneclearing_d/</loc>
		<lastmod>2018-07-04T15:38:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0c4accytheris_initiates_phase_iiia_study_of_hepatitis/</loc>
		<lastmod>2018-07-04T15:38:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/10492clinical_data_to_acquire_avalon_pharmaceut/</loc>
		<lastmod>2018-07-04T15:38:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/324admedimetriks_licenses_prescription_brands_from_perrigo_co/</loc>
		<lastmod>2018-07-04T15:38:28+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-neurocrines-ingrezza-to-treat-tardive-dyskinesia-120417-5785221/</loc>
		<lastmod>2018-07-04T15:38:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/scotland-approves-new-drugs-for-hiv-cancer-and-others-110417-5784233/</loc>
		<lastmod>2018-07-04T15:38:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/takeda-nubiyota-to-collaborate-on-microbiome-therapeutics-110417-5784336/</loc>
		<lastmod>2018-07-04T15:38:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ee49aothera_wins_new_patent_for_treatment_of_ophthalmic_dis/</loc>
		<lastmod>2018-07-04T15:38:31+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5048chitech_pharmacal_wins_final_approval_for_ocular_hypertension/</loc>
		<lastmod>2018-07-04T15:38:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e448cadvanced_viral_research_initiates_phase_iib_wound_healing_/</loc>
		<lastmod>2018-07-04T15:38:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6f4afsmiths_medical_wins_threeyear_supply_contract_from_nov/</loc>
		<lastmod>2018-07-04T15:38:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/accenture-biocelerate-to-advance-biopharmaceutical-innovation-110417-5784322/</loc>
		<lastmod>2018-07-04T15:38:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/roches-alecensa-shows-significant-effect-over-pfizers-xalkori-to-treat-alk-positive-nsclc-110417-5784046/</loc>
		<lastmod>2018-07-04T15:38:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ibm-gets-us-patent-for-machine-learning-models-used-for-drug-discovery-100417-5783057/</loc>
		<lastmod>2018-07-04T15:38:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4f4a1galapagos_and_chdi_sign_new_collaboration_agree/</loc>
		<lastmod>2018-07-04T15:38:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2c4bdmurigen_and_csl_restructure_drug_development_collabor/</loc>
		<lastmod>2018-07-04T15:38:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5549cchmp_awards_positive_opinion_for_myelodysplastic_syndrome/</loc>
		<lastmod>2018-07-04T15:38:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a849arecordati_acquires_yeni_i/</loc>
		<lastmod>2018-07-04T15:38:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9c4aacompellis_wins_second_us_patent_for_new_obesity_th/</loc>
		<lastmod>2018-07-04T15:38:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/medivirs-ctcl-drug-remetinostat-yields-positive-data-in-phase-ii-study-100417-5783110/</loc>
		<lastmod>2018-07-04T15:38:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/harvoni-sovaldi-get-fda-approval-for-new-indications-in-hcv-pediatric-patients-100417-5783095/</loc>
		<lastmod>2018-07-04T15:38:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-secures-fdas-complete-response-letter-for-diabetes-drug-januvia-100417-5782852/</loc>
		<lastmod>2018-07-04T15:38:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/354bdpharmathene_initiates_phase_i_study_of_nerve_agent_bioscav/</loc>
		<lastmod>2018-07-04T15:38:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immune-onc-to-partner-with-university-of-texas-on-novel-cancer-immunotherapy-070417-5781881/</loc>
		<lastmod>2018-07-04T15:38:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/36482caliper_to_sell_pdq_product_line_to_sotax_for_158_mi/</loc>
		<lastmod>2018-07-04T15:38:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/30481corindus_names_new_president_an/</loc>
		<lastmod>2018-07-04T15:38:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b7486glaxosmithkline_to_acquire_genelabs_for_57_mi/</loc>
		<lastmod>2018-07-04T15:38:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f74b1affitech_acquires_diabody_technology_from_pha/</loc>
		<lastmod>2018-07-04T15:38:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/burosumabs-pediatric-phase-2-studies-in-x-linked-hypophosphatemia-yield-positive-results-070417-5781919/</loc>
		<lastmod>2018-07-04T15:38:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regenerons-evinacumab-gets-fda-breakthrough-therapy-status-to-treat-hofh-070417-5781764/</loc>
		<lastmod>2018-07-04T15:38:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/894b7mdrna_names_new_chief_scientific_of/</loc>
		<lastmod>2018-07-04T15:38:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eisai-and-meiji-enter-into-agreement-for-parkinsons-disease-drug-in-asian-countries-060417-5780618/</loc>
		<lastmod>2018-07-04T15:38:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/finch-and-takeda-to-jointly-develop-microbiome-therapeutics-in-ibd-060417-5780633/</loc>
		<lastmod>2018-07-04T15:38:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/allergan-to-advance-botox-trial-to-third-phase-for-treatment-of-depression-060417-5780534/</loc>
		<lastmod>2018-07-04T15:38:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7c487memory_pharmaceuticals_granted_new_us_p/</loc>
		<lastmod>2018-07-04T15:38:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b14a3barrs_subsidiary_duramed_wins_fda_approval_for_oral_contrace/</loc>
		<lastmod>2018-07-04T15:38:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/494bcbiowa_signs_licensing_agreement_with_kalobios_pharmaceut/</loc>
		<lastmod>2018-07-04T15:38:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1c4a8laureate_pharma_signs_cgmp_contract_manufacturing_agreement_with_t/</loc>
		<lastmod>2018-07-04T15:38:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/verona-does-first-patient-in-cystic-fibrosis-phase-2a-trial-050417-5779455/</loc>
		<lastmod>2018-07-04T15:38:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/aviragen-therapeutics-to-explore-strategic-alternatives-050417-5779430/</loc>
		<lastmod>2018-07-04T15:38:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/parateks-omadacycline-succeeds-in-late-stage-pneumonia-trial-050417-5779371/</loc>
		<lastmod>2018-07-04T15:38:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a649aroche_and_exiqon_sign_licensing_agre/</loc>
		<lastmod>2018-07-04T15:38:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1e499ikonisys_wins_fda_clearance_for_breast_cancer/</loc>
		<lastmod>2018-07-04T15:38:48+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/03498bayer_wins_european_license_approval_for_new_sterile_filling_fac/</loc>
		<lastmod>2018-07-04T15:38:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/02495biocryst_reports_positive_results_from_phase_ii_influenza_/</loc>
		<lastmod>2018-07-04T15:38:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4949cconcert_reports_encouraging_results_for_oxazolidinone_antib/</loc>
		<lastmod>2018-07-04T15:38:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-accepts-to-review-abbvies-snda-for-ibrutinib-in-cgvhd-050417-5779169/</loc>
		<lastmod>2018-07-04T15:38:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-tevas-austedo-for-treating-chorea-in-hd-patients-040417-5778076/</loc>
		<lastmod>2018-07-04T15:38:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/eu-approves-novartis-tafinlar-mekinist-combination-for-nsclc-treatment-040417-5778118/</loc>
		<lastmod>2018-07-04T15:38:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/644b7gpc_biotech_reports_encouraging_preclinical_data_from_leukemia_/</loc>
		<lastmod>2018-07-04T15:38:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c9497anadys_initiates_dosing_in_phase_ib_hepatitis_/</loc>
		<lastmod>2018-07-04T15:38:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/654a6nycomed_reports_encouraging_preliminary_results_from_phase_iii_copd_st/</loc>
		<lastmod>2018-07-04T15:38:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2b4bftherapure_biopharma_and_induce_biologics_announce_collabor/</loc>
		<lastmod>2018-07-04T15:38:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/sucampo-purchases-vtesse-for-200m-040417-5778141/</loc>
		<lastmod>2018-07-04T15:38:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e84b2polyremedy_names_ne/</loc>
		<lastmod>2018-07-04T15:38:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/japans-astellas-to-acquire-belgian-firm-ogeda-for-eur800m-040317-5777892/</loc>
		<lastmod>2018-07-04T15:38:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/gsk-commences-late-stage-study-of-mepolizumab-in-severe-hes-patients-030417-5776795/</loc>
		<lastmod>2018-07-04T15:38:55+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c348csalient_surgical_raises_179_million_in_series_f_fina/</loc>
		<lastmod>2018-07-04T15:38:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5f484china_sky_one_medical_acquires_breast_drug_from_harbin_medical_unive/</loc>
		<lastmod>2018-07-04T15:38:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f84a4targeted_genetics_reports_positive_results_from_phase_iii_arthritis_/</loc>
		<lastmod>2018-07-04T15:38:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a54b9cook_medical_wins_ce_mark_approval_for_miraflex_high_flow_microcat/</loc>
		<lastmod>2018-07-04T15:38:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/34499zosano_reports_positive_results_from_phase_ii_osteoporosis_/</loc>
		<lastmod>2018-07-04T15:38:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgen-ucb-explore-option-of-second-course-of-treatment-with-evenity-030417-5776873/</loc>
		<lastmod>2018-07-04T15:38:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/verona-pharma-appoints-new-commercial-director-030417-5776854/</loc>
		<lastmod>2018-07-04T15:38:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-astrazenecas-tagrisso-to-treat-mutation-positive-nsclc-030417-5776617/</loc>
		<lastmod>2018-07-04T15:38:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2b4b4galenea_and_organix_sign_license_agre/</loc>
		<lastmod>2018-07-04T15:39:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6f4aborasure_files_premarket_approval_application_for_hepatitis/</loc>
		<lastmod>2018-07-04T15:39:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b948echelsea_completes_enrollment_for_phase_ii_arthritis_/</loc>
		<lastmod>2018-07-04T15:39:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/redx-pharma-secures-grant-from-carb-x-to-accelerate-antibacterial-innovation-310317-5775601/</loc>
		<lastmod>2018-07-04T15:39:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/immuno-oncology-company-agenus-announces-restructuring-of-business-310317-5775560/</loc>
		<lastmod>2018-07-04T15:39:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/corbus-anabasum-shows-significant-effect-in-cystic-fibrosis-study-310317-5775303/</loc>
		<lastmod>2018-07-04T15:39:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/31484antisoma_names_ne/</loc>
		<lastmod>2018-07-04T15:39:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0648ehitech_pharmacal_receives_final_approval_for_dorzolamide_ophthalmic_sol/</loc>
		<lastmod>2018-07-04T15:39:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4c4a7phenomix_initiates_phase_ia_hepatitis_/</loc>
		<lastmod>2018-07-04T15:39:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b4484provectus_completes_phase_i_breast_cancer_/</loc>
		<lastmod>2018-07-04T15:39:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a490infinity_pharmaceuticals_names_new_president_and_chief_business_of/</loc>
		<lastmod>2018-07-04T15:39:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0d495infacare_pharmaceutical_raises_28_million_in_series_b_fina/</loc>
		<lastmod>2018-07-04T15:39:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5f4bdoxigene_reports_positive_interim_results_from_phase_ii_cancer_/</loc>
		<lastmod>2018-07-04T15:39:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ritters-lactose-intolerance-treatment-rp-g28-succeeds-in-phase-2b3-trial-300317-5774322/</loc>
		<lastmod>2018-07-04T15:39:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/warp-drive-gsk-form-alliance-to-discover-new-drugs-for-oncology-and-other-diseases-300317-5774310/</loc>
		<lastmod>2018-07-04T15:39:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-roches-ocrevus-for-relapsing-and-primary-progressive-forms-of-ms-300317-5774122/</loc>
		<lastmod>2018-07-04T15:39:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-grants-priority-review-to-astrazenecas-ovarian-cancer-drug-lynparza-280317-5773562/</loc>
		<lastmod>2018-07-04T15:39:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d149abristolmyers_reports_positive_results_from_phase_iiib_arthritis_/</loc>
		<lastmod>2018-07-04T15:39:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/1d483lilly_introduces_color_differentiation_system_for_u100_insulin_products_/</loc>
		<lastmod>2018-07-04T15:39:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d449fcarna_biosciences_signs_distribution_agreement_with/</loc>
		<lastmod>2018-07-04T15:39:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/tesaros-zejula-approved-by-fda-for-recurrent-ovarian-cancer-280317-5773062/</loc>
		<lastmod>2018-07-04T15:39:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/uks-university-of-dundee-gets-grant-to-discover-new-antibacterial-drugs-280317-5773120/</loc>
		<lastmod>2018-07-04T15:39:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a34a0novartis_reports_encouraging_results_from_phase_iii_caps_/</loc>
		<lastmod>2018-07-04T15:39:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d84bfastellas_introduces_graceptor_capsules_in_/</loc>
		<lastmod>2018-07-04T15:39:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/summit-to-extend-phaseout-dmd-trial-for-ezutromid-280317-5773099/</loc>
		<lastmod>2018-07-04T15:39:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/allergan-parateks-acne-drug-sarecycline-meets-primary-endpoint-in-two-phase-3-trials-280317-5772791/</loc>
		<lastmod>2018-07-04T15:39:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f94bdjohnson__johnson_acquires_health/</loc>
		<lastmod>2018-07-04T15:39:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/96494immunogen_receives_4_million_milestone_payment_from_sanofiav/</loc>
		<lastmod>2018-07-04T15:39:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ignyta-lilly-to-collaborate-on-taladegib-oncology-program-270317-5771992/</loc>
		<lastmod>2018-07-04T15:39:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8e4aaardea_reports_encouraging_data_from_phase_i_hyperuricemia_and_gout_/</loc>
		<lastmod>2018-07-04T15:39:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3148bariad_presents_positive_results_from_preclinical_studies_of_tumor/</loc>
		<lastmod>2018-07-04T15:39:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ac49bpacgen_signs_letter_of_intent_with_medigen_biotechn/</loc>
		<lastmod>2018-07-04T15:39:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/puretech-health-novartis-partner-to-advance-mtorc1-programmes-270317-5771982/</loc>
		<lastmod>2018-07-04T15:39:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/xenons-acne-drug-xen801-fails-in-phase-2-trial-270317-5771967/</loc>
		<lastmod>2018-07-04T15:39:16+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/genentech-gets-fda-nod-for-rituxan-to-treat-pemphigus-vulgaris-270317-5771706/</loc>
		<lastmod>2018-07-04T15:39:17+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bf495roche_reports_positive_results_from_phase_iii_arthritis_st/</loc>
		<lastmod>2018-07-04T15:39:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/224b4infinity_presents_positive_data_from_phase_i_study_of_tumor/</loc>
		<lastmod>2018-07-04T15:39:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5648dsepracor_wins_eu_positive_opinion_for_insomnia_dru/</loc>
		<lastmod>2018-07-04T15:39:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c24a4vaxart_reports_positive_data_from_preclinical_studies_of_oral_avian_flu_va/</loc>
		<lastmod>2018-07-04T15:39:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7a48fmedas_nda_for_new_formulation_of_allergy_drug_accepted_b/</loc>
		<lastmod>2018-07-04T15:39:19+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0b48bcypress_bioscience_introduces_two_new_personalized_medicine_ser/</loc>
		<lastmod>2018-07-04T15:39:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgens-amgevita-gets-approved-in-europe-for-certain-inflammatory-diseases-240317-5770797/</loc>
		<lastmod>2018-07-04T15:39:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biolinerx-acquires-agalimmune-for-expanding-immuno-oncology-pipeline-240317-5770804/</loc>
		<lastmod>2018-07-04T15:39:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/merck-pfizer-get-fda-nod-for-bavencio-to-treat-metastatic-merkel-cell-carcinoma-240317-5770575/</loc>
		<lastmod>2018-07-04T15:39:22+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e04b3paratek_reports_positive_results_from_phase_ii_skin_infections_/</loc>
		<lastmod>2018-07-04T15:39:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/174a6kamada_completes_final_analysis_of_phase_iii_aat_deficiency_/</loc>
		<lastmod>2018-07-04T15:39:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/004b4sanofi_pasteur_presents_positive_results_from_phase_iii_influenza_vaccine_/</loc>
		<lastmod>2018-07-04T15:39:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/184b2boston_scientific_wins_canadian_approval_for_two_new_cardiac_de/</loc>
		<lastmod>2018-07-04T15:39:23+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ce492vaxinnate_presents_positive_results_from_phase_i_flu_vaccine_/</loc>
		<lastmod>2018-07-04T15:39:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/914b9array_biopharma_reports_positive_results_from_phase_ii_dental_pain_/</loc>
		<lastmod>2018-07-04T15:39:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6649dincyte_presents_positive_results_from_phase_iia_study_of_arthritis/</loc>
		<lastmod>2018-07-04T15:39:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/4f487acusphere_signs_financing_agreement_with_cep/</loc>
		<lastmod>2018-07-04T15:39:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ce4b2recordati_signs_licensing_agreement_with_kowa_pharmaceutical_e/</loc>
		<lastmod>2018-07-04T15:39:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/biogen-prevails-in-ms-drug-tecfidera-patent-case-5769767/</loc>
		<lastmod>2018-07-04T15:39:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/akashi-gets-fda-nod-for-clinical-development-of-dmd-drug-ht-100-230317-5769790/</loc>
		<lastmod>2018-07-04T15:39:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/regeneron-partners-with-uk-biobank-and-gsk-on-genetic-sequence-data-230317-5769778/</loc>
		<lastmod>2018-07-04T15:39:30+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3c48aomrix_to_resume_enrollment_in_us_phase_ii_fibrin_pad_/</loc>
		<lastmod>2018-07-04T15:39:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a84aevaxine_makes_bid_to_acquire_protein_sci/</loc>
		<lastmod>2018-07-04T15:39:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d84b5infinity_initiates_phase_iii_registration_study_of_tumor/</loc>
		<lastmod>2018-07-04T15:39:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b44bawatson_files_patent_infringement_lawsuit_against/</loc>
		<lastmod>2018-07-04T15:39:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ba495ivivi_technologies_signs_nonbinding_term_sheet_with_recove/</loc>
		<lastmod>2018-07-04T15:39:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-serelaxin-fails-to-meet-primary-endpoint-in-heart-failure-study-230217-5769505/</loc>
		<lastmod>2018-07-04T15:39:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/x-chem-ono-to-collaborate-on-multi-target-drug-discovery-220317-5768641/</loc>
		<lastmod>2018-07-04T15:39:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pierre-fabre-h-immune-partner-on-immuno-oncology-therapeutics-220317-5768670/</loc>
		<lastmod>2018-07-04T15:39:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/df4aavaleant_pharmaceuticals_signs_promotion_agreement_with_glaxosmith/</loc>
		<lastmod>2018-07-04T15:39:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a348bstellar_pharmaceuticals_signs_licensing_agreement_wit/</loc>
		<lastmod>2018-07-04T15:39:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8148fbiotie_therapies_to_acquire_e/</loc>
		<lastmod>2018-07-04T15:39:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/newrons-xadago-gets-fda-nod-to-treat-parkinsons-disease-220317-5768618/</loc>
		<lastmod>2018-07-04T15:39:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fd4aatempo_pharmaceuticals_changes_name_to_cerulean_p/</loc>
		<lastmod>2018-07-04T15:39:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d5490celgene_wins_chmp_positive_opinion_for_cancer/</loc>
		<lastmod>2018-07-04T15:39:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/lillys-abemaciclib-meets-primary-endpoint-in-phase-3-breast-cancer-trial-210317-5767686/</loc>
		<lastmod>2018-07-04T15:39:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/nektars-nktr-181-shown-to-reduce-chronic-pain-in-phase-3-trial-210317-5767711/</loc>
		<lastmod>2018-07-04T15:39:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6f4bespiration_wins_fdas_hde_approval_for_bronchial_/</loc>
		<lastmod>2018-07-04T15:39:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/044betarganta_reports_promising_in_vivo_data_from_c_difficile_infection_/</loc>
		<lastmod>2018-07-04T15:39:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/014aeribxs_phase_ii_skin_structure_infections_study_meets_end_/</loc>
		<lastmod>2018-07-04T15:39:38+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/52497ortho_clinical_wins_fda_clearance_for_vitros_5600_integrated_s/</loc>
		<lastmod>2018-07-04T15:39:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/224adbristolmyers_squibb_reports_encouraging_results_from_hiv_/</loc>
		<lastmod>2018-07-04T15:39:39+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/salvarx-to-invest-in-antibody-developer-rift-biotherapeutics-210317-5767723/</loc>
		<lastmod>2018-07-04T15:39:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bms-cytomx-expand-collaboration-to-discover-novel-therapeutics-for-cancer-210317-5767384/</loc>
		<lastmod>2018-07-04T15:39:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/oxford-biodynamics-to-take-part-in-collaboration-on-rheumatoid-arthritis-relapses-200317-5766664/</loc>
		<lastmod>2018-07-04T15:39:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c3495lilly_receives_chmp_negative_opinion_for_fibromyalgia/</loc>
		<lastmod>2018-07-04T15:39:41+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/59485pg_announces_encouraging_results_from_genomic_study_of_common/</loc>
		<lastmod>2018-07-04T15:39:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f44b7astellas_withdraws_european_maa_for_antibiotic_drug_cand/</loc>
		<lastmod>2018-07-04T15:39:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c048finspire_reports_positive_results_from_phase_iii_cystic_fibrosis_/</loc>
		<lastmod>2018-07-04T15:39:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8348fminster_pharmaceuticals_reports_positive_results_from_phase_ii_migraine_/</loc>
		<lastmod>2018-07-04T15:39:42+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/circassia-secures-us-rights-for-two-astrazeneca-copd-drugs-for-230m-200317-5766626/</loc>
		<lastmod>2018-07-04T15:39:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/novartis-entresto-improves-glycemic-control-in-phase-3-study-200317-5766649/</loc>
		<lastmod>2018-07-04T15:39:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/amgens-cholesterol-drug-shows-positive-effect-in-cardiovascular-outcomes-study-200317-5766473/</loc>
		<lastmod>2018-07-04T15:39:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a14b2merck_serono_files_snda_for_new_indication_of_infertility/</loc>
		<lastmod>2018-07-04T15:39:45+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/shires-hae-drug-cinryze-secures-label-extension-in-europe-170317-5765464/</loc>
		<lastmod>2018-07-04T15:39:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cell-medica-secures-60m-financing-for-multiple-cancer-programmes-170317-5765161/</loc>
		<lastmod>2018-07-04T15:39:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ptc-to-acquire-emflaza-for-duchenne-muscular-dystrophy-treatment-in-us-170317-5765156/</loc>
		<lastmod>2018-07-04T15:39:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/b74b3vgx_international_signs_master_product_sale_agreement_with_bioca/</loc>
		<lastmod>2018-07-04T15:39:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c1482johnson__johnson_files_new_drug_application_for_seizure/</loc>
		<lastmod>2018-07-04T15:39:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/cb4a9bristolmyers_squibb_reports_200_surge_in_q3_ear/</loc>
		<lastmod>2018-07-04T15:39:46+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/a54b0sanofiaventis_suspends_marketing_authorization_of_obesity_drug_in_e/</loc>
		<lastmod>2018-07-04T15:39:47+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/61483davita_coo_to_r/</loc>
		<lastmod>2018-07-04T15:39:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/scientists-discover-genetic-change-in-non-coding-dna-to-cause-neurodevelopmental-disorders-160317-5764471/</loc>
		<lastmod>2018-07-04T15:39:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mhra-grants-early-access-to-sanofis-dermatology-treatment-160317-5764457/</loc>
		<lastmod>2018-07-04T15:39:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/catalyst-pharmaceuticals-neuromuscular-drug-succeeds-in-seven-patient-trial-160317-5764395/</loc>
		<lastmod>2018-07-04T15:39:49+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/594b2origenis_broadens_drug_discovery_research_alliance_with_/</loc>
		<lastmod>2018-07-04T15:39:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/2e481novexel_reports_positive_results_from_phase_ii_pneumonia_/</loc>
		<lastmod>2018-07-04T15:39:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/084b4eli_lilly_reports_q3_net/</loc>
		<lastmod>2018-07-04T15:39:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/0e49cproteolix_reports_encouraging_results_from_phase_i_cancer_/</loc>
		<lastmod>2018-07-04T15:39:50+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/astrazenecas-lynparza-improves-lifetime-in-ovarian-cancer-patients-during-phase-3-trial-5763280/</loc>
		<lastmod>2018-07-04T15:39:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/crispr-casebia-sign-commercial-license-agreement-with-maxcyte-150317-5763343/</loc>
		<lastmod>2018-07-04T15:39:52+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/c54acvitae_pharmaceuticals_names_ne/</loc>
		<lastmod>2018-07-04T15:39:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fb4a7cytochroma_initiates_phase_ii_chronic_kidney_disease_/</loc>
		<lastmod>2018-07-04T15:39:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-launches-zavicefta-in-uk-and-germany-150317-5763317/</loc>
		<lastmod>2018-07-04T15:39:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/364acgilead_to_purchase_building_and_adjacent_land_in_foster_city_fro/</loc>
		<lastmod>2018-07-04T15:39:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/74481boston_scientific_wins_fda_approval_for_carotid_artery_/</loc>
		<lastmod>2018-07-04T15:39:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/704a7sanofiaventis_and_medicines_for_malaria_venture_announce_collabor/</loc>
		<lastmod>2018-07-04T15:39:54+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/mercks-keytruda-gets-fda-approval-to-treat-classical-hodgkin-lymphoma-150317-5762912/</loc>
		<lastmod>2018-07-04T15:39:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/daiichi-sankyo-heptares-to-jointly-develop-small-molecules-for-pain-treatment-140317-5762113/</loc>
		<lastmod>2018-07-04T15:39:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/uncategorized/scientists-claim-novel-method-to-tackle-undruggable-disease-causing-proteins-140317-5762054/</loc>
		<lastmod>2018-07-04T15:39:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7049epatheon_opens_new_pds_suite_in_c/</loc>
		<lastmod>2018-07-04T15:39:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/3349fauspex_reports_positive_results_from_phase_i_depression_/</loc>
		<lastmod>2018-07-04T15:39:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/5648aaddrenex_initiates_phase_ii_hypertension_/</loc>
		<lastmod>2018-07-04T15:39:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/e14bcarginetix_raises_23_million_in_fina/</loc>
		<lastmod>2018-07-04T15:39:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/f648agsk_acquires_rights_to_affiriss_alzheimers_disease_vaccine_pro/</loc>
		<lastmod>2018-07-04T15:39:58+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/indivior-reports-positive-results-in-phase-3-trial-of-schizophrenia-drug-risperidone-140317-5762102/</loc>
		<lastmod>2018-07-04T15:39:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/fda-approves-novartis-kisqali-to-treat-metastatic-breast-cancer-140317-5761814/</loc>
		<lastmod>2018-07-04T15:39:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/synairgen-reveals-positive-data-for-loxl2-inhibitors-in-lung-fibrosis-100317-5760647/</loc>
		<lastmod>2018-07-04T15:40:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/bb4b6calando_pharmaceuticals_completes_phase_i_cancer_/</loc>
		<lastmod>2018-07-04T15:40:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/9f4bfopexa_reports_additional_positive_data_from_phase_iib_multiple_sclerosis_/</loc>
		<lastmod>2018-07-04T15:40:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/ef485ariad_reports_encouraging_preclinical_data_from_prostate_cancer_/</loc>
		<lastmod>2018-07-04T15:40:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/7149cnovis_pharmaceuticals_names_new_cha/</loc>
		<lastmod>2018-07-04T15:40:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/6b4aascheringploughs_schizophrenia_relapse_prevention_trial_meets_primary_end/</loc>
		<lastmod>2018-07-04T15:40:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/boehringers-bi-836858-granted-orphan-drug-designation-by-fda-100317-5760188/</loc>
		<lastmod>2018-07-04T15:40:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/spero-therapeutics-gets-517m-in-new-funding-round-100317-5760172/</loc>
		<lastmod>2018-07-04T15:40:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/pfizer-serviers-ind-for-leukemia-drug-candidate-ucart19-gets-fda-clearance-100317-5759979/</loc>
		<lastmod>2018-07-04T15:40:03+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/d3495synexus_to_double_clinical_trial_capacity_in_south_a/</loc>
		<lastmod>2018-07-04T15:40:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.pharmaceutical-business-review.com/news/8c4b6celera_extends_license_agreement_with_na/</loc>
		<lastmod>2018-07-04T15:40:05+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->